Trading Analysis Report: ARM¶

Analysis date: 2026-10-21
Rating: Underweight
Generated: 2026-10-21 13:53:48
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 226.71 Price As Of: 2026-10-21

(The tools don't label a currency. ARM is listed on NMS/Nasdaq, so this is presumably USD.)

Data integrity notes¶

Last-bar discrepancy. get_stock_data shows the 2026-10-21 bar with close 226.86 and volume 1,809,370. The verified snapshot shows close 226.71 and volume 1,810,297. Open (225.82), high (228.95) and low (219.50) match in both. I use the snapshot figures throughout and have not reconciled the two.
Likely a live bar. The OBV series moves from 407,128,000 to 408,938,297 on 10-21, a change of exactly 1,810,297, so it agrees with the snapshot volume. A volume of about 1.8M is also well below the 4–7M of recent sessions. This is my inference, not something a tool confirmed. Treat today's close, volume and any indicator built on them as provisional.
Indicators not pulled. I didn't pull td_9, so I have no exhaustion count. I took the 10-EMA and the Bollinger values from the snapshot, not from separate indicator calls.

Indicators chosen and why¶

I picked eight indicators that don't overlap:

Role	Indicator
Medium- and long-term trend	`close_50_sma`, `close_200_sma`
Multi-timeframe trend regime and stop	`supertrend`
Trend momentum	`macd`
Overbought/oversold	`rsi`
Volatility and risk sizing	`atr`
Volume confirmation	`obv`
Statistical stretch	`z_score`

The stock is down about 48% from its June peak, trading near its long-term average and still very volatile. That makes the long-term trend line, the multi-timeframe regime, momentum, volatility and a stretch gauge the useful set.

1. Price structure (from dated closes)¶

Dec 2025 low. The close fell from 169.38 (2025-10-21) to 109.31 (2025-12-31).
Spring 2026 advance. From 109.31 the stock rose to a closing high of 439.46 on 2026-06-18, about +302%. That day's volume was 34.2M, the heaviest of the sample alongside the 3/25 (29.6M) and ⅚ (26.3M) sessions. The intraday high was 452.70.
First distribution leg. The close fell to 224.89 on 2026-07-29 (low 222.56), and the intraday low reached 219.39 on 2026-08-03.
Rebound and lower high. The stock rebounded to 333.20 on 2026-09-22 after a 13.0M-volume gap and surge on 9-21 (close 322.90, up from 275.61 on 9-18). That high sits well below the June peak of 439.46.
Current leg down. Closes ran from 307.49 (10-02) to 221.06 (10-20). Today's 226.71 is about -48.4% from the June closing high, -32.0% from the 9-22 close and -26.3% from the 10-02 close. These are my calculations from the dated closes.
Stance versus July–August lows. The 10-20 close of 221.06 is slightly below the 7-29 closing low of 224.89. The 10-20 intraday low of 217.26 is slightly below the 8-3 low of 219.39. That 217–225 zone has been marginally undercut, not decisively broken.
Prior reaction in that zone. After the 8-3 low of 219.39, the stock closed at 280.56 on 8-4. That is one observation, not a validated support level.

2. Trend¶

Moving averages (snapshot and indicator series)

Average	Value	Price vs. it
10-EMA	243.58	Price about 6.9% below
50-SMA	265.01	Price about 14.5% below; falling since a 270.50 peak on 10-13
200-SMA	225.12	Price about 0.7% above

200-SMA. It is rising by roughly 0.5 per day (208.22 on 9-21 to 225.12 on 10-21). Price is sitting almost exactly on it.
Recent behavior against the 200-SMA. Within the 30-day window, the only close below it was 10-20 (221.06 vs. 224.57). The 10-21 close is back above it, but only marginally.
Short-term damage. Price is below both the 10-EMA and the 50-SMA, so the short- and medium-term trend is down.
50/200 relationship. The 50-SMA is still above the 200-SMA, so no death cross has formed. The gap has narrowed from 52.8 points on 9-21 to 39.9 points now. A cross is not imminent on current numbers.

SuperTrend (weekly > monthly > daily)

Tier	Direction	Stop line	Close vs. line
Weekly (primary)	DOWN	357.54	-36.59%
Monthly (regime)	UP	198.17	+14.40%
Daily (timing)	DOWN	271.64	-16.54%

Weighting. The weekly downtrend outranks the monthly uptrend, so the primary read is bearish.
Weekly line. It is far away. A flip would need roughly a 58% rally to 357.54.
Monthly line. At 198.17 it is the last higher-tier uptrend support in the toolset. A monthly close below it would put all three tiers in downtrends.
Daily line. At 271.64 it is the nearest trend-flip level for entry timing.

3. Momentum¶

MACD (macd -13.74, signal -6.21, histogram -7.52) - The MACD line crossed below zero on 10-13 (from +1.87 on 10-12 to -0.51). It has fallen every session since 10-02, when it was 11.14. - It is below its signal line, so this is a bearish configuration. - The decline is slowing. The daily drops were about -2.09, -2.08 and then -1.03 on the latest (provisional) bar. - That is a deceleration in downside momentum, not a reversal signal. There is no bullish crossover.

RSI (35.70) - It peaked at 71.36 on 9-22 and fell to a low of 32.84 on 10-20. - It hasn't reached the 30 oversold threshold in the window. - Price made a lower low on 10-20 (221.06 vs. 227.80 on 10-16) and RSI made a lower low too (32.84 vs. 34.49). There is no bullish divergence. - The uptick to 35.70 matches today's bounce and has not been confirmed.

4. Volatility and risk sizing¶

ATR is 15.97, about 7.0% of price. It fell from 19.83 on 9-28, but relative to price it is essentially unchanged (19.83 / 283.33 ≈ 7.0%). The dollar drop reflects the lower share price, not calmer trading. Expect daily swings of roughly 16 points.
Illustrative ATR distances from 226.71:
1× ATR ≈ 16.0
2× ATR ≈ 31.9 (about 194.8 on the downside)
3× ATR ≈ 47.9
Bollinger Bands (snapshot): middle 271.08, upper 333.71, lower 208.45. Price is about 8% above the lower band and about 20% below the middle. The bands are very wide, about 46% of the middle line. The upper band still reflects the 9-22/23 spike and will drift lower as those bars roll out of the 20-day window.

5. Volume¶

OBV is 408.9M. It peaked in the window at 437.7M on 9-22 and was 430.1M on 10-02, so it is down modestly (about 6.6% from the peak) while price fell much more.
OBV since 10-12. It has held in a 406–413M band while price dropped from 255.24 to 226.71. That is a mild positive divergence, which is low-confidence. OBV adds the full day's volume on any up-close. For example, 10-13 closed +0.15 on 6.78M shares, which flatters the series.
No capitulation volume. The heaviest recent sell-off sessions had volume of 6.2–6.8M (10-08, 10-13, 10-14, 10-15). Volume faded to 4.1–5.2M on 10-16 to 10-20. A washout spike like the 13–34M bars seen earlier is absent, and the 10-21 reading is provisional.

6. Stretch (Z-score)¶

Weekly -1.12, monthly +0.57, daily -1.42.
None of the tiers reaches the |z| ≥ 2 threshold, so there is no statistical oversold signal.
The daily figure is consistent with the Bollinger inputs. The monthly figure is positive because the multi-month run-up is still inside the monthly window.

7. Key levels (tool-derived only)¶

Above price - 10-EMA at 243.58. - The 10-12/10-13 closes at about 255.2–255.4. - 50-SMA at 265.01. - Bollinger middle at 271.08. - Daily SuperTrend at 271.64. - 9-22 close at 333.20. - Weekly SuperTrend at 357.54.

Below price - 200-SMA at 225.12, rising. - 10-20 close at 221.06 and intraday low at 217.26. - 8-3 intraday low at 219.39. - Bollinger lower band at 208.45. - Monthly SuperTrend at 198.17.

8. What the tools support¶

Bias. The primary trend is bearish. The weekly and daily SuperTrends are down, price is below the 10-EMA and 50-SMA, and MACD is negative and below its signal. The monthly regime is still up.
Pivot zone. The 200-SMA and the 217–225 July–August low cluster are the same area, around 217–225. Whether it holds is the main near-term question. Price has probed it on a closing and intraday basis without a decisive break.
No oversold confirmation. RSI is above 30, the Z-scores are inside ±2, and there is no capitulation volume. The indicators don't flag an exhausted sell-off, so further downside would not be unusual.
Early signs of slowing. MACD's rate of decline is slowing, volume on the decline has faded since 10-15, and OBV has held flat since 10-12. These are tentative and rest partly on a provisional bar.
Confirmation levels.
Improvement: a sustained close back above the 10-EMA (243.58), then 255.2–255.4. The daily SuperTrend flip level is 271.64.
Deterioration: closes below about 217–219, then the Bollinger lower band (208.45) and the monthly SuperTrend (198.17).
Sizing. With ATR near 7% of price, stops inside about 1× ATR (16 points) sit within normal daily noise.

This is a read of what the indicators show, not a trade decision.

Summary table¶

Item	Reading	Interpretation
Close (snapshot)	226.71 (2026-10-21)	Bar likely provisional; stock-data tool shows 226.86
Drawdown	-48.4% from 439.46 (6-18); -32.0% from 333.20 (9-22)	Large, ongoing correction (computed from dated closes)
10-EMA	243.58	Price below; short-term trend down
50-SMA	265.01 (falling)	Price about 14.5% below; medium-term trend down
200-SMA	225.12 (rising)	Price about 0.7% above; key pivot, tested on 10-20
SuperTrend weekly	DOWN, stop 357.54	Primary trend bearish
SuperTrend monthly	UP, stop 198.17	Regime still up; a monthly close below flips it
SuperTrend daily	DOWN, stop 271.64	Entry-timing trend down
MACD / signal / hist	-13.74 / -6.21 / -7.52	Bearish; zero-line cross down on 10-13; decline slowing
RSI	35.70 (low 32.84 on 10-20)	Weak, not oversold; no bullish divergence
ATR	15.97 (about 7.0% of price)	Very high volatility; relative level unchanged
Bollinger (snapshot)	208.45 / 271.08 / 333.71	Price in lower half; bands very wide
OBV	408.9M (peak 437.7M on 9-22)	Modest decline; flat since 10-12 (mild, low-confidence positive divergence)
Volume	6.2–6.8M on heavy down days; 1.81M today (provisional)	No capitulation spike
Z-score W / M / D	-1.12 / +0.57 / -1.42	No stretch extreme
Support references	225.12 (200-SMA), 217.26–224.89 (July–Oct lows), 208.45, 198.17	Zone marginally undercut, not decisively broken
Resistance references	243.58, about 255.3, 265.01, 271.08/271.64	Overhead supply stacks up between 243 and 272
Not covered	`td_9` exhaustion count	Not pulled

Sentiment Analyst¶

Overall Sentiment: Mixed (Score: 5.0/10) Confidence: Low

Scope and data limits. This report covers ARM (Arm Holdings plc, NMS) for 2026-10-14 to 2026-10-21. Reddit was disabled by configuration, so only two of three sources are available. The news feed has 14 headlines with no article bodies or timestamps, so the direction and details of the Qualcomm ruling cannot be confirmed from the evidence. StockTwits has 30 messages, of which only 10 carry a sentiment label. These gaps drive the low confidence.

1. Source-by-source breakdown

News (Yahoo Finance, 14 headlines, institutional framing). The headlines fall into four groups: - ARM-specific litigation and risk (4): 'Judge Reluctant to Intervene in Qualcomm-Arm Licensing Talks' (MT Newswires); 'Arm Stock Verdict Risk Grows After Qualcomm License Breach Ruling' and 'Arm Holdings Faces License Breach Questions, Is The Valuation Still Too Rich?' (both Simply Wall St); and 'Arm and AMD Fall 5% as Qualcomm Verdict Adds to Chip Selloff' (24/7 Wall St). This is the only hard, event-type negative in the set. It ties a roughly 5% single-day drop to the Qualcomm verdict, and the second Simply Wall St headline questions whether the valuation is too rich. - Constructive ARM-focused pieces (4): three Motley Fool articles ('Arm vs. Lumentum', 'Arm vs. Credo', 'Not AMD. Not Broadcom. This is the Chip Designer Nvidia Investors Should Be Watching') plus 24/7 Wall St's 'The Next AI Stock Wall Street Is Starting to Pay Attention To'. These are opinion or promotional content and carry less weight than the litigation headlines. - Sector tape (4): the sector sold off, then recovered. 'Chip Stocks Continue Downward Streak, Pricing In A Crash' (IBD) and 'Chip stocks shrug off a scary morning, but history says the shakeout isn't over' are cautious. 'Chip stocks recover as AI jitters fade' and 'Intel leads chip stocks higher as investors jump back into AI trade' show a rebound. The net picture is a volatile, V-shaped sector with unresolved AI-trade anxiety. - Peripheral (2): the Intel/TSMC packaging story and SoftBank's security-guard robotics bid have low direct relevance to ARM.

News net read: mildly bearish to mixed. The negative items are factual (litigation, a drop, valuation), while the positive items are mostly opinion.

StockTwits (30 most-recent messages, retail, fast-moving). The labeled split is Bullish 8 (27%), Bearish 2 (7%), Unlabeled 20 (67%). That is 80/20 among labeled posts, but on only 10 labels, and the bullish count is concentrated. @jd4308 supplies 5 of the 8 bullish tags, so there are only about 4 distinct bullish authors (@jd4308, @VossNorway, @lifeonthewater, @mangledtrader) against 2 bearish authors (@FreyBentos, @USStockDesk). The ratio is therefore weaker evidence than it looks. - Bullish substance: @jd4308 reads the judge's comments (Judge Noreika, closing arguments on Oct 20) as unwilling to allow a 5-year pause on payments to ARM. The same author claims a '900% increase' in AI-side revenue, which is unverified and not supported by anything in the news feed. @VossNorway cites a Tom's Hardware piece in which Arm claims its AGI CPU delivers double the performance per rack of AMD EPYC 9755. @lifeonthewater says the 50% retracement 'is done'. - Bullish positioning and flow: @Swift_Trades flags unusual ARM options flow on Oct 20 of 9.8k calls vs 1.5k puts (6.5x). @TopOptionAlert posts a NOV20 $230C setup with an entry zone of $219.51-$222.61, invalidation on a close under $217.26, and objectives of $236.59 and $245.87. @LiveTradePro cites ARM at $218.56 as a dip-buy example. @cash38 exited at $223.30. - Bearish and anxious tone: @FreyBentos says ARM is a 'mature company valued like a growth stock' at a $236B market cap on $4-5B of annual revenue and expects a fall toward the IPO price. @USStockDesk tagged ARM/SOXL bearish on Oct 20, then on Oct 21 wrote 'added more to SOXL and ARM', so that trader flipped long within a day. Unlabeled posts show stress: '25% correction in one month', 'wholly Armageddon batman', 'The AI Bubble Has Already Burst' (a blog link) and 'US Equity markets are now in bear markets'. Others ask whether to buy the dip or whether ARM will head toward the 250s. - Noise: the @kobby_jr post is off-topic, and several posts only tag ARM among many tickers (OKLO, SMCI, SOXL).

StockTwits net read: mildly bullish on labels and options flow, but the unlabeled majority shows dip-buying mixed with capitulation-style fear.

Reddit: not available, since it was disabled by configuration. No inference is drawn about r/wallstreetbets, r/stocks or r/investing.

2. Cross-source divergences and alignments - Divergence on the Qualcomm dispute. News framing is cautious: 'verdict risk grows', 'license breach questions', and a 5% drop attributed to the verdict. Retail labeled posts treat the Oct 20-21 courtroom commentary as a win for ARM. The ruling's direction and scope cannot be verified from headlines alone. The MT Newswires headline ('judge reluctant to intervene in licensing talks') is ambiguous and could imply the parties are pushed toward negotiating. Retail may be over-reading it, or news may be lagging it. - Alignment on volatility. Both sources show a sharp drawdown followed by a bounce. News describes a sector shakeout and recovery, and retail cites a roughly 25% one-month correction, a stabilization around $218-$223, and call buying. - Alignment on valuation unease. Simply Wall St and @FreyBentos both question whether ARM's valuation is too rich, which makes it a cross-source bear argument. - Contrarian read. Retail dip-buying and heavy call flow after a large drawdown can mean either early accumulation or crowded optimism. With only 10 labels, there is no sign of the 90/10 over-extension that would flag a clear contrarian risk.

3. Dominant narrative themes 1. The Qualcomm-Arm licensing and breach dispute is the single biggest ARM-specific driver. 2. The semiconductor and AI-trade shakeout and rebound ('pricing in a crash' versus 'AI jitters fade'). 3. Valuation: a growth multiple on modest revenue, with bears citing the IPO price as a magnet. 4. AI and product optimism: the AGI CPU performance claim and 'next AI stock' framing. 5. Short-term trading structure, covering specific levels ($217.26 invalidation, $219-$223 zone, $230 and $236-$246 targets) and options positioning.

4. Catalysts and risks surfaced by the data - Catalysts (upside): a favorable or clarifying outcome in the Qualcomm dispute that restores royalty and licensing visibility; independent validation of the AGI CPU performance claim; continued recovery in the AI and semiconductor trade; bullish options positioning. - Risks (downside): an adverse or prolonged Qualcomm outcome ('verdict risk grows'); renewed chip-sector selling ('the shakeout isn't over'); a rich valuation if growth disappoints; macro weakness (SPX red on Oct 21, the 'AI bubble burst' narrative); and event risk from the earnings-season catalysts retail is watching (Meta after the close on Oct 21, post-earnings range-trading expectations for SMH/AMD/AVGO/MU, SMCI/NFLX results). Retail technical traders flag a loss of the roughly $217 area as invalidation. - Missing from the evidence: no ARM closing price or percent move for the week, no article bodies, no analyst rating or target changes, no ARM earnings date, and no Reddit data.

5. Summary table of key sentiment signals

Signal	Direction	Source	Supporting evidence
Qualcomm license breach ruling and verdict risk	Bearish (news) / ambiguous	News	'Verdict Risk Grows', 'License Breach Questions', ARM and AMD down 5% on the verdict; judge 'reluctant to intervene' in talks
Retail read of the judge's comments	Bullish	StockTwits	@jd4308: judge not allowing a 5-year pause on payments (opinion, unverified)
Sector selloff and rebound	Mixed	News	'Pricing In A Crash' and 'shakeout isn't over' vs 'AI jitters fade' and 'Intel leads chip stocks higher'
Valuation concern	Bearish	News + StockTwits	Simply Wall St 'valuation too rich?'; @FreyBentos: $236B market cap, expects a fall toward the IPO price
Labeled retail ratio	Mildly bullish (low n)	StockTwits	8 bullish / 2 bearish / 20 unlabeled of 30; 5 of 8 bullish tags from @jd4308
Unusual options flow	Bullish	StockTwits	@Swift_Trades: 9.8k calls vs 1.5k puts (6.5x); NOV20 $230C setup
AGI CPU product claim	Bullish	StockTwits	@VossNorway: 2x performance per rack vs AMD EPYC 9755 (Tom's Hardware link)
Retail fear and drawdown	Bearish / contrarian	StockTwits	'25% correction in one month', 'Armageddon', 'AI bubble has already burst'
Short-term levels	Neutral / technical	StockTwits	Support $217.26, zone $219.51-$222.61, targets $236.59 / $245.87; dip at $218.56, exit at $223.30
Trader reversal (@USStockDesk)	Mixed	StockTwits	Bearish ARM/SOXL on Oct 20, added to ARM/SOXL on Oct 21
Promotional and comparison articles	Mildly bullish (low weight)	News	Motley Fool x3, 24/7 'Next AI Stock'
Reddit	Unavailable	n/a	Disabled by config; no read

Bottom line. Sentiment on ARM is Mixed. Institutional news emphasizes legal and valuation risk and a volatile chip sector, while retail leans bullish on the labeled posts and call flow after a sharp pullback. The sample is thin (10 labels, headlines only, no Reddit), so this is a signal to weigh alongside fundamentals and technicals, not a price call.

News Analyst¶

ARM (Arm Holdings plc) – News and Macro Report, 14–21 Oct 2026¶

1. Data coverage and gaps¶

Macro data is unavailable. Every FRED call failed. The alias calls (fed_funds_rate, 10y_treasury, cpi, unemployment, vix, yield_curve) returned a parse error. The raw-ID retries (DGS10, FEDFUNDS) returned 403 Forbidden. I have no readings for policy rate, yields, inflation, unemployment, VIX or the curve, and I haven't estimated any. The macro view below rests only on prediction markets and headlines.
News items are headlines and links only. I didn't get article text or per-item dates. The details of the Qualcomm ruling and ARM's price levels aren't in my data, so I don't state them.
Some prediction markets are thin. The Nvidia Q3 markets have only a few hundred to a few thousand dollars of volume. Treat them as noise.

2. ARM company news¶

Main driver: the Qualcomm–Arm licensing dispute. - Headlines say a verdict or ruling on a Qualcomm license breach came out this week. Simply Wall St. wrote "Arm Stock Verdict Risk Grows After Qualcomm License Breach Ruling" and "Arm Holdings (ARM) Faces License Breach Questions, Is The Valuation Still Too Rich?". - 24/7 Wall St. reported "Arm and AMD Fall 5% as Qualcomm Verdict Adds to Chip Selloff; Taiwan Semiconductor Slips." The market treated the verdict as negative for ARM, with a roughly 5% drop on the day. - MT Newswires reported "Judge Reluctant to Intervene in Qualcomm-Arm Licensing Talks." The court appears unwilling to force a commercial resolution, so licensing terms between the two will probably be settled by negotiation, not by the judge. - The headlines don't make the exact holding clear. Someone needs to read the ruling to see what it says on damages, appeal rights and licence terms. That matters because Qualcomm is a major licensee and royalty payer.

Sector context: AI-driven chip volatility. - IBD reported chip stocks on a downward streak, "pricing in a crash". Yahoo Finance followed with "Chip stocks shrug off a scary morning, but history says the shakeout isn't over." - Later headlines say chips recovered as "AI jitters fade", with Intel leading a rebound as investors "jump back into the AI trade." - TIKR reported Intel fell nearly 6% after TSMC moved on its packaging business. That's a competitive-dynamics signal for foundry and packaging. - ARM trades with the semiconductor and AI complex and also has its own legal overhang. That adds idiosyncratic risk on top of sector beta.

Sentiment and valuation commentary. - Motley Fool ran several comparison pieces (ARM vs. Lumentum, ARM vs. Credo), and 24/7 Wall St. ran "The Next AI Stock Wall Street Is Starting to Pay Attention To". Retail and media interest in ARM as an AI name is high. - The "valuation still too rich?" framing suggests the multiple is a debated risk when headlines turn negative. - Another Motley Fool piece, "Not AMD. Not Broadcom. This is the Chip Designer Nvidia Investors Should Be Watching", is promotional commentary. It carries no hard data.

SoftBank link. - SoftBank is ARM's majority owner. One headline says SoftBank wants to buy America's biggest security-guard company and use robots. It's tangential, but it shows SoftBank is still pursuing AI and robotics deals. Capital allocation at SoftBank (a possible ARM stake sale or margin financing) is a standing overhang to watch.

3. Macro and market backdrop¶

Prediction markets (Polymarket): - Fed, October meeting (resolves 29 Oct): - No change: 86%, up 20pp on the week. - 25bp hike: 14%, down 19.5pp on the week. A week ago a hike was priced at roughly a third. - Cut of any size: ~0%. - The market has moved sharply away from a hike, but a hold is far from certain. - Fed cuts in 2026: "No cuts in 2026" is at 97%. Cut-count markets (6, 9, 10, 11, 12+) are at 0%. There's no policy easing to support high-multiple tech this year. With a hike still at 14% for October, the risk is tilted toward tighter, not looser, policy. - Recession: US recession by end-2026 is 8%. UK is 6% and Japan 4%, both on thin volume. Hard-landing risk is priced low. - AI bubble: "AI bubble burst in 2026" is 10%, up 3.5pp on the week. "By 30 Jun 2027" is 20% on very thin volume. The probability is low, but it is rising in a week when chips sold off. - Taiwan: A Chinese invasion by end-2026 is 2%, with $44.5M of volume. A blockade in 2026 is 2%, and a military clash before 2027 is 3%. These are low and falling slightly. This matters because TSMC is critical to ARM's ecosystem, and 10% for an invasion by end-2027 is a small but nonzero tail. - Nvidia Q3 (resolves 18 Nov): Data Center revenue above $100B is priced at 81%, and above $110B at 19%. Volumes are tiny, so I wouldn't lean on them. Nvidia's report on 18 Nov is still a likely sector catalyst for ARM.

Global headlines: - Pre-bell coverage said stocks were rising as traders awaited Meta and Tesla earnings. Mega-cap AI capex commentary is a read-through for ARM. - IBM Q3 earnings were expected to show about 8% EPS growth, and there is Palantir and quantum-stock commentary. The AI-software and speculative-tech tape looks mixed. Rigetti and IonQ (down about half in a year) point to selectivity in speculative tech. - Silver is described as showing more resilience than gold. I have no price data to draw a conclusion from this.

4. Implications for traders (evidence-based, not a trade call)¶

Event risk is asymmetric. The Qualcomm ruling already produced a ~5% down day. Further headlines such as an appeal, a settlement or a damages decision could move ARM sharply in either direction. A settlement or new licence terms would likely be a relief catalyst. The judge's reluctance to intervene makes a negotiated outcome more plausible than a court-imposed one. This is inference from the headlines, not confirmed.
Sector beta is high. ARM fell with AMD and TSMC on the selloff day, and chips rebounded on "AI jitters fade". ARM is likely to move with Nvidia, TSMC and hyperscaler capex news. Key dates:
Meta and Tesla earnings (this week).
The FOMC decision (28–29 Oct).
Nvidia's report (18 Nov).
Rates are a headwind for the multiple. Markets price no 2026 cuts and a 14% chance of an October hike. A long-duration, richly valued stock like ARM is vulnerable if the Fed's tone turns hawkish. The fall in hike odds is a modest positive.
Tail risks are priced low but not zero. The AI-bubble-burst odds are rising from 10%, the Taiwan tail is 2%, and the US recession probability is 8%.
Verify before acting. Because FRED was unavailable, the next analyst should independently check yields, CPI, unemployment, VIX and the actual fed funds level. They should also read the full Qualcomm ruling and get ARM's price, volume and technicals, which I didn't have.

5. Summary table¶

Area	Key point	Source / evidence	Read-through for ARM
Qualcomm–Arm dispute	A "license breach" ruling this week. ARM fell about 5%.	24/7 Wall St., Simply Wall St.	Negative near term; holding details unverified
Court stance	Judge reluctant to intervene in licensing talks	MT Newswires	Points to a negotiated outcome; settlement is an upside catalyst
Chip sector	Selloff ("pricing in a crash"), then a rebound as AI jitters fade	IBD, Yahoo Finance	ARM trades with sector beta; volatile
Competitive landscape	TSMC targeting Intel's packaging business; Intel fell ~6%	TIKR	Ecosystem shift; indirect
Valuation	"Too rich?" debate; heavy retail and media coverage	Simply Wall St., Motley Fool	Multiple compression risk on bad news
SoftBank	Majority owner pursuing AI and robotics deals	24/7 Wall St.	Capital-allocation overhang
Fed, Oct meeting	Hold 86%; hike 14% (down 19.5pp); cut ~0%	Polymarket	Hawkish tail has eased but remains
Fed, 2026	No cuts in 2026: 97%	Polymarket	No easing tailwind
Recession	US 8%; UK 6%; Japan 4%	Polymarket	Low hard-landing risk
AI bubble	Burst in 2026: 10% (up 3.5pp); by mid-2027: 20% (thin volume)	Polymarket	Low but rising
Taiwan	Invasion by end-2026: 2%; blockade 2%; clash 3%	Polymarket	Low tail risk; supply-chain critical
Upcoming catalysts	FOMC 28–29 Oct; Meta and Tesla earnings; Nvidia 18 Nov	Polymarket, MT Newswires	Sector and rate-driven moves
Macro data (CPI, yields, unemployment, VIX, curve)	Unavailable (FRED parse error and 403)	Tool failure	Not assessed; verify independently

Fundamentals Analyst¶

ARM (Arm Holdings plc) – Fundamental Analysis Report¶

As of 2026-10-21 | Technology / Semiconductors | NMS | Fiscal year ends March 31

1. Bottom line¶

The business is very profitable at the gross level and growing about 20–25% a year. Gross margin is about 97%, cash is about $3.1B, and debt is minimal.
The valuation is extreme. Market cap is about $242B, which is about 47x TTM sales and about 234x trailing GAAP earnings. The forward P/E of 74x assumes forward EPS roughly triples from the trailing $0.97 to $3.06.
Operating leverage is moving the wrong way. Operating expenses (gross profit minus operating income) are growing faster than revenue. Fiscal Q1 FY27 (June 2026) operating margin was 7.1%, versus 10.8% a year earlier and 19.4% two years earlier.
GAAP net income is well above operating income. In the latest quarter net income was $270M against operating income of $91M. I would not treat that gap as recurring.
Insiders have been net sellers only. The data shows about $72M of sales and no open-market purchases since March 2026. The size is trivial against a $242B market cap, but the one-way direction is a sentiment point.
The stock is volatile. My derived price is about $227, roughly 50% below the 52-week high of $452.70. It is just above the 200-day average and about 15% below the 50-day average.

2. Company profile and valuation snapshot¶

Metric	Value	Comment
Market cap	$242.3B
Implied share price	about $227	My derivation from P/B × book value and from P/E × EPS. The tool returned no direct quote.
52-week range	$100.02 – $452.70	The price sits about 36% of the way up the range and about 50% below the high.
50-day / 200-day average	$265.85 / $224.57	The price is about 14.6% below the 50-day and about 1% above the 200-day.
P/E (TTM)	233.9x	Based on GAAP EPS of $0.97
Forward P/E	74.1x	Based on forward EPS of $3.06
PEG	1.87
Price/Book	28.1x	Book value is $8.08 per share.
Price/Sales (TTM)	about 47x	My calculation
EV/EBITDA (TTM)	about 225x	My calculation, using about $3.06B cash and about $0.49B debt
FCF yield	about 0.55%	Vendor FCF of $1.33B
Beta	3.79	Treat with caution. The trading history is short (the IPO was in September 2023) and the figure is extreme.
Dividend yield	0%
ROE / ROA	13.4% / 5.4%
Debt/Equity	5.6%	Debt is about $0.49B, implied from the ratio.
Current ratio	5.25

Valuation context: - The forward EPS of $3.06 is probably a non-GAAP estimate that excludes stock-based compensation. The tools don't confirm this. If so, it isn't comparable with the $0.97 GAAP trailing figure, and the apparent drop from 234x to 74x overstates how much cheaper the stock is. - As an illustration only, suppose revenue compounds at 20% for five years, from $5.16B to about $12.8B, at a 25% net margin. Net income would be about $3.2B. Today's $242B market cap would still be about 76x those earnings. The price assumes sustained high growth plus margin expansion.

3. Income statement¶

3a. Annual (USD millions)¶

FY (Mar)	Revenue	YoY	Gross profit	Op. income	Op. margin	Net income	Diluted EPS
FY22	2,703	–	2,572	633	23.4%	549	0.54
FY23	2,679	-0.9%	2,573	671	25.0%	524	0.51
FY24	3,233	+20.7%	3,079	111	3.4%	306	0.29
FY25	4,007	+23.9%	3,886	831	20.7%	792	0.75
FY26	4,920	+22.8%	4,799	900	18.3%	904	0.85

Revenue growth has held at about 21–24% for three straight years.
FY24's weak operating income ($111M) lines up with the Sept-2023 quarter's operating loss of $156M, which was likely IPO-related stock compensation. The tool doesn't state the cause.
FY26 operating expenses were about $3.9B, up 27.6% from about $3.06B in FY25. Revenue grew 22.8%, so margin fell from 20.7% to 18.3%.

3b. Recent quarters (USD millions)¶

Q4 figures are derived: the annual figure minus the three reported quarters.

Quarter	Period end	Revenue	YoY	Gross profit	Op. income	Op. margin	Net income	EPS
Q1 FY26	Jun-25	1,053	+12.1%	1,023	114	10.8%	130	0.12
Q2 FY26	Sep-25	1,135	+34.5%	1,106	163	14.4%	238	0.22
Q3 FY26	Dec-25	1,242	+26.3%	1,212	185	14.9%	223	0.21
Q4 FY26 (derived)	Mar-26	1,490	+20.1%	1,458	438	29.4%	313	~0.30
Q1 FY27	Jun-26	1,289	+22.4%	1,253	91	7.1%	270	0.25

Observations: 1. Revenue is lumpy. It fell 13.5% sequentially from Q4 FY26 to Q1 FY27. Q4 appears to be seasonally strong (Q4 FY25 derived operating margin was about 33%), and Q1 appears to be weak. 2. Q1 operating margin has fallen three years running: 19.4% (Jun-24), 10.8% (Jun-25), 7.1% (Jun-26). 3. Operating expenses are rising quickly. They were about $1,020M in Q4 FY26 and about $1,162M in Q1 FY27, up about 14% sequentially. They were up about 28% from $909M in Q1 FY26. The tools give no R&D or SG&A breakdown, so I can't say whether this is hiring, stock compensation or one-off items. 4. Earnings quality is a concern. Net income has exceeded operating income in every recent quarter except Q4 FY26. The latest gap is about $179M ($270M vs $91M). Interest income on about $3B of cash explains only a small part, so the rest is probably tax benefits or other items. I can't verify this with these tools. 5. TTM figures reconcile with the vendor's numbers. - TTM revenue is $5,156M, TTM gross profit $5,029M, and TTM net income $1,044M. - TTM operating income is about $877M, a 17.0% TTM operating margin. - The vendor's "operating margin 7.6%" matches the latest quarter, not the TTM. Don't read it as the annual run-rate.

4. Balance sheet (USD millions)¶

Date	Total assets	Current assets	Cash & equiv.	Total liabilities	Current liabilities	Equity
Mar-23	6,866	3,537	1,554	2,815	1,363	4,051
Mar-24	7,927	4,197	1,923	2,632	1,505	5,295
Mar-25	8,932	4,830	2,085	2,093	929	6,839
Mar-26	10,703	6,236	2,751	2,417	1,040	8,286
Jun-26	11,196	6,339	3,058	2,566	1,207	8,630

Liquidity is very strong.
The current ratio is about 5.25.
Cash rose $307M in the June quarter.
Equity is about 77% of assets.
Debt is about 5.6% of equity.
Net cash is at least about $2.5B, before any short-term investments the tool doesn't break out.
Equity is growing fast. It rose from $6.84B to $8.63B (+26%) in 15 months. Some of that is retained earnings and some is likely stock compensation added to equity.
Cash is small relative to the valuation. At $3.06B it is about 1.3% of the $242B market cap, so the balance sheet offers little valuation support.

5. Cash flow (USD millions)¶

Annual¶

FY	Operating CF	Capex	FCF (OCF – capex)	FCF / revenue	Investing CF	Financing CF
FY22	458	34	424	15.7%	-619	-32
FY23	739	64	675	25.2%	-138	-42
FY24	1,090	92	998	30.9%	-516	-208
FY25	397	219	178	4.4%	-35	-202
FY26	1,524	545	979	19.9%	-325	-548

Latest quarter (Q1 FY27, Jun-26)¶

Operating cash flow was $902M and capex $197M, so FCF was about $705M.
Investing outflow was $267M and financing outflow $326M.
These flows reconcile to the +$307M change in cash.
Don't annualize this quarter.
Operating cash flow was 3.3x net income and 2.7x the year-ago quarter ($332M).
That points to working-capital timing, probably collections.
The tools don't show the receivables or deferred revenue detail.

Key points¶

Operating cash flow is lumpy. FY25 OCF was only $397M, against $1,090M in FY24 and $1,524M in FY26.
Capex is rising quickly.
It went from $92M in FY24 to $219M in FY25 to $545M in FY26, and is about $588M TTM.
That is about 11% of revenue, up from 2.8% in FY24.
The tools don't say what it funds.
TTM FCF has two figures. The vendor reports $1.33B. My TTM build (FY26 – Q1 FY26 + Q1 FY27) gives about $1.51B (OCF about $2.09B, capex about $0.59B). The gap is probably a definition difference. Either way, FCF yield is below 1%.
Financing outflows have grown. They were -$548M in FY26 and -$326M in the June 2026 quarter alone. The composition is not shown. It could be tax withholding on share settlements, buybacks or lease payments.

6. Insider transactions (Mar–Oct 2026)¶

Net activity: no open-market purchases. I summed the transactions the tool labeled as sales, which come to about $72M.

Insider	Role	Sales	Approx. value	Price range / timing
Jason Child	CFO	5 sales, about 95,280 shares	about $20.0M	$148 (Mar) → $300 (Sep 21). Includes 10,400 shares on both Aug 27 ($255) and Sep 21 ($300).
Spencer Collins	Officer	2 sales, about 92,900 shares	about $19.8M	$208–215 (May 11 and 19)
William Abbey	Officer	6 sales, about 43,800 shares	about $12.0M	$199 → $415 (May 15 – Jun 1)
Rene Haas	CEO	2 sales, about 41,150 shares	about $6.6M	about $160–163 (Mar 26, Apr 14)
Richard Grisenthwaite	Officer	24,339 shares	about $5.1M	$209 (May 18)
Laura Bartels	Officer	11,306 shares	about $4.4M	$392.70 (Jun 2)
Charlotte Eaton	Officer	14,905 shares	about $4.2M	$252–291 (May 21)

Other items: - Grants on 2026-05-15: - The CEO received 265,643 shares, the CFO 81,359, Collins 69,117 and Abbey 23,310. - Grisenthwaite received 22,690 and Eaton 5,612. - Several blank-priced entries the same day are probably vesting or tax-withholding events. The tool doesn't label them. - Director Jeffrey Sine gifted 9,572 shares on 8/7. The CEO's 64-share award on 8/31 is immaterial. - Nothing in the past week. The last sale was the CFO's on Sep 21.

Interpretation: - Selling clustered from May 11 to Jun 2, right after the May 15 vest, as the stock roughly doubled from about $200 to about $400. Selling into a rally is normal for executives holding large equity awards. - The CFO's identical lot sizes (21,280 twice, 10,400 twice) look systematic, as pre-arranged plans usually do. The tool doesn't confirm that. - The CFO's $300 sale on Sep 21 compares with an implied price of about $227 now. That is about 24% lower, and about 50% below the June high. - The size is small relative to market cap, but the absence of any insider buying while the stock is down about 50% from its high is worth noting.

7. Risks and watch items¶

Valuation: 234x trailing earnings, about 47x sales and an FCF yield below 1% leave little room for a growth or margin miss.
Margin compression: Operating expenses are growing about 5 points faster than revenue, and Q1 margins have fallen three years in a row. Watch whether the Q2 FY27 operating margin recovers from Q1's 7.1%.
Earnings quality: GAAP net income is running well above operating income, and the Q1 FY27 gap was about $179M. Look for the source (tax, interest or other income) in the filings.
Cash flow volatility: OCF swung from $1,090M to $397M to $1,524M across FY24–FY26, and the $902M June-quarter figure is probably timing-driven.
Rising capital intensity: Capex is up about 6x in two years. Whether it earns a return depends on how it is being used.
Price volatility: The beta of 3.79 and a 52-week range of $100–$453 mean large swings. The stock moved from about $415 to about $227 in under five months.
Upcoming catalyst: The quarter ending Sep 30 has not been reported, since the latest data is June 2026. Based on prior-year timing, results are probably due in early November, but the tools don't confirm the date. The Q4 FY26 versus Q1 FY27 pattern suggests quarterly results can swing sharply.

Limits of this data: - It comes from SEC EDGAR facts via the tools. - It has no segment split (royalty vs. licensing), no remaining performance obligations, no guidance, no R&D/SG&A/SBC detail and no news or analyst data. - Fiscal Q4 columns are absent from the quarterly statements, so I derived them from the annual figures.

8. Summary table¶

Category	Key Data	Takeaway for traders
Valuation	Market cap $242B; P/E 234x TTM, 74x forward; P/S about 47x; P/B 28x; PEG 1.87	Priced for sustained high growth. The forward EPS basis (likely non-GAAP) is unverified.
Price context	About $227 implied; 52-week range $100–$453; 50-day $266, 200-day $225	Down about 50% from the high. About 15% below the 50-day and near the 200-day.
Revenue growth	FY24 +20.7%, FY25 +23.9%, FY26 +22.8%; Q1 FY27 +22.4% YoY	Consistent 20%+ growth. Quarterly results are lumpy (Q1 FY27 was -13.5% vs Q4).
Gross margin	About 97%	Very asset-light economics.
Operating margin	FY26 18.3%; TTM 17.0%; Q1 FY27 7.1% (Q1 FY26 10.8%, Q1 FY25 19.4%)	Operating expenses are growing about 28% against revenue growth of about 22%, so leverage is negative.
Earnings quality	Q1 FY27 net income $270M vs operating income $91M	The gap is probably non-operating or tax items. Verify before relying on EPS.
Profitability	TTM net income $1.04B (20.2% margin); EPS $0.97; ROE 13.4%	Healthy, but the valuation leaves little margin for error.
Balance sheet	Cash $3.06B; debt about $0.49B; current ratio 5.25; equity $8.63B	Fortress balance sheet with no financial-distress risk.
Cash flow	FY26 OCF $1.52B, capex $0.55B, FCF $0.98B; Q1 FY27 OCF $902M	FCF yield is below 1%. Q1 OCF is likely timing-inflated.
Capex trend	$92M (FY24) → $219M → $545M (FY26); about $588M TTM	Capex is rising sharply (about 11% of revenue). Purpose is not given in the data.
Insider activity	About $72M of sales since March 2026; zero purchases; last sale Sep 21 (CFO, $300)	Consistently one-way selling, much of it after the May vest. Small relative to market cap.
Risk flags	Beta 3.79; margin compression; lumpy OCF; extreme multiples	High volatility. Results are likely early November (date unconfirmed).
Data gaps	No segment, guidance, R&D/SBC or news data; fiscal Q4s derived	A further agent with news and technical tools should fill these in.

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for ARM: Growth and Quality at a Reset Price

I'll open with the case, then address the bear arguments I expect, since the valuation point is the obvious one.

1. The business compounds at 20%+ with software-like economics¶

Steady growth: Revenue grew +20.7% in FY24, +23.9% in FY25 and +22.8% in FY26, and the latest quarter (Q1 FY27) was +22.4% YoY. Three-plus years of 21-24% growth is a durable trend, not a one-quarter spike. Revenue is up about 59% since FY24 ($3.23B to $5.16B TTM).
Gross margin of about 97%: ARM sells designs, not wafers. Incremental revenue falls almost entirely to gross profit, so operating leverage can return once the cost base stops outrunning revenue.
Fortress balance sheet: Cash is $3.06B, debt is about $0.49B, the current ratio is 5.25 and equity is $8.63B. There is no financing risk and no dilution pressure from a cash crunch.
Real cash generation: TTM operating cash flow is about $2.09B against GAAP net income of $1.04B, and TTM FCF is $1.3-1.5B. The earnings are backed by cash.

2. The price has already reset¶

At $226.71 the stock is -48.4% from the June closing high of $439.46. Market cap has roughly halved, from about $470B to $242B, while fundamentals kept growing. The peak premium has been squeezed out.

The technical picture at this level is better than the headline drawdown suggests:

The stock is at the 200-SMA ($225.12), which is rising by about $0.50 a day. It probed that zone on 10-20 (close $221.06, low $217.26) and closed back above it today. Today's bar looks provisional, so I'd only call that a first sign.
The 217-225 zone coincides with the July-August lows. The last time the stock touched $219.39 (8-3), it closed at $280.56 the next day. That's one observation, not a validated floor, but the zone has drawn buyers before.
The monthly SuperTrend is still UP, with its line at $198.17.
Downside momentum is fading. The MACD daily drops shrank from -2.09 and -2.08 to -1.03. Selling volume fell from 6.2-6.8M to 4.1-5.2M. OBV has been flat since 10-12 while price dropped, a mild positive divergence.

Risk/reward is definable. A close under about $217 is the first warning. The monthly SuperTrend at $198 is the regime line, about 12.6% below. Upside references are $271.64 (daily SuperTrend, +20%) and $333.20 (the 9-22 high, +47%). That's about 1.6:1 to the first target and 3.7:1 to the second, measured against the regime line. A stop inside one ATR (about $16) is just noise, so size positions for a 7% daily range.

3. Positioning isn't crowded¶

Sentiment is a Mixed 5.0/10, which is not euphoria. Unlabeled retail posts say "Armageddon" and "AI bubble has already burst," while options flow showed 9.8k calls to 1.5k puts on 10-20. That's fear in the commentary and accumulation in the flow.
Labeled StockTwits posts are 8 bullish to 2 bearish, but that's only 10 labels and 5 of the 8 bullish tags come from one author. I won't lean on it. The point is only that it isn't the 90/10 pile-in that precedes tops.
Macro odds have improved at the margin. The October hike probability fell from about a third to 14%, recession odds are 8%, an AI-bubble burst in 2026 is 10% and Taiwan tail risk is 2%. "No cuts in 2026" (97%) is already priced in.

4. The bear arguments I expect¶

"234x trailing earnings, 47x sales." I concede it's expensive, and I won't pretend 234x is cheap. But trailing GAAP EPS of $0.97 undersells the earnings power. Forward P/E is 74x, though that forward EPS of $3.06 is probably non-GAAP and I can't confirm it. The more important point is that the multiple has already compressed by half in four months. Valuation is a risk to size for, not a reason the thesis is broken.

"Margins are compressing." This is the bear's best fundamental point. Q1 FY27 operating margin was 7.1% against 10.8% a year ago, and operating income fell from $114M to $91M on 22% revenue growth. Three things temper it: 1. Q1 is the seasonally weakest quarter. Revenue fell 13.5% sequentially while the cost base didn't. 2. When revenue lands, the leverage shows. Q4 FY26 operating margin was 29.4% ($438M of operating income). 3. TTM operating margin is 17.0%, not 7.1%.

The data doesn't tell us what the opex growth is funding, so the November report matters. If Q2 margin doesn't recover from 7.1%, I'll say so.

"Net income exceeds operating income, so earnings quality is poor." The gap ($270M vs $91M) needs explaining. But cash flow corroborates earnings, with TTM OCF at twice net income. A cash-rich, cash-generative company isn't manufacturing profits.

"Insiders are only selling." About $72M of sales is 0.03% of a $242B market cap. The sales clustered after the May 15 vest, and the CFO's lots look systematic, which suggests pre-arranged plans. The CEO sold about 41K shares in the period and received a 266K-share grant. This is ordinary executive-equity behavior. I'd concede the lack of any insider buying is a soft sentiment negative.

"The Qualcomm ruling." This is the real overhang, and I can't tell you from headlines alone who won what. What the evidence shows: - The reported reaction was a roughly 5% down day. The stock is down 48% from its peak, so one ruling explains only a small slice of the drawdown. - The judge is reported as reluctant to intervene in licensing talks. That points toward a negotiated outcome, and a settlement would be a relief catalyst, though that's my inference. - Retail posts claim the judge won't allow a 5-year pause on payments to ARM. That's unverified, and I flag it as such.

"Weekly SuperTrend is DOWN, so don't catch a falling knife." Agreed, the primary trend is bearish and I won't dispute it. The weekly flip level is $357.54, so confirmation will come much later and at much higher prices. My case is that the risk is defined here and the regime line is below us. If the monthly SuperTrend breaks, all three tiers are down and I'm wrong.

5. Catalysts¶

FOMC, 28-29 Oct: hold odds are 86%, and a hawkish tail has been fading.
ARM earnings: probably early November (date unconfirmed). Last time, margin and revenue both swung hard quarter to quarter.
Nvidia, 18 Nov: the Data Center >$100B market is at 81%, though it's thin.
Qualcomm resolution: a settlement or clarified terms would remove the biggest idiosyncratic overhang.
AGI CPU claims: Arm says 2x performance per rack versus AMD EPYC 9755. That's a company claim relayed by retail and unverified, but independent validation would support the growth thesis.

What would change my mind¶

A monthly close below $198.17.
Q2 operating margin staying near 7% with revenue growth below 20%.
A Qualcomm outcome that cuts into royalty visibility.

The bear needs to explain how a business growing 20%+ with 97% gross margin, a $3B cash cushion and strong cash conversion deserves a falling-knife label at a price where the long-term average, the monthly regime and prior buyers all sit within a few percent. Where do you think the thesis breaks? Bull Analyst: # Bull Rebuttal: I'll Concede the Price, Defend the Business, and Put Numbers on the Test

You landed real hits. Here is what I'm taking, where I think you overreach, and direct answers to your two questions.

1. What I concede¶

Seasonality. Q1-vs-Q1 already controls for it, so 19.4% → 10.8% → 7.1% is a trend. My point only explained why 7.1% sits below TTM, not why it keeps falling.
"Reset." I measured from the June peak. Against a year ago, the multiple is back in the mid-40s on TTM sales, so ARM is not cheap on any anchor except the peak.
Technicals I leaned on.
The 200-SMA slope is mostly arithmetic from old ~$110 closes rolling off.
RSI shows no divergence.
There is no capitulation volume, so I'm not calling a bottom.
The 9.8k/1.5k options post is one retail post with unknown direction, so I withdraw it as evidence of accumulation.
Macro. The AI-bubble odds are up 3.5pp on the week, which I omitted. I'm treating macro as neutral at best.
Risk/reward isn't an edge. In a driftless market, a -12.6%/+47% payoff hits the upside first about 21% of the time (12.6 / 59.6) for zero expected value. Levels only define risk, and the edge has to come from fundamentals.
My kill criterion was conjunctive. I've fixed it below.

2. Where the bear case goes further than the evidence¶

The Q2 extrapolation is one branch, not the base case. Opex ran $943M → $1,027M → $1,020M → $1,162M, so Q1's +14% sequential jump was a level shift. The open question is whether it repeats. Assuming Q2 revenue is +22% (about $1,385M) at Q1's 97.2% gross margin (about $1,346M gross profit):

Q2 opex	Op. income	vs $163M last year
$1,162M (flat QoQ)	~$184M	+13%
$1,183M (+1.8% QoQ)	~$163M	flat
$1,207M (+28% YoY, your case)	~$139M	-15%

Your case needs opex to rise another ~4% sequentially on top of Q1's step-up. It's possible, but the whole gap between margin recovery and a second straight YoY decline is about $45M of cost on a $1.2B base. That is why the print is a coin-flip with real downside at 47x sales. It is not a foregone conclusion.

What opex funds. I can't say, but there are three testable hypotheses: 1. A stock-comp step-up from the May 15 grant cycle (the insider file shows 265,643 shares to the CEO and 81,359 to the CFO that day). 2. Headcount and R&D. 3. Product investment. The retail-relayed AGI CPU claim, which is unverified, would also fit the capex ramp.

I'm raising a risk against myself here. If it's silicon, mix could eventually pressure the 97% gross margin, which was still 97.2% in Q1. The November 10-Q should show SBC and R&D.

Growth, through your two-year lens. Q1's +22.4% is about 17% annualized because it came on the easy +12.1% comp. Q2 faces the hardest comp in the series (+34.5%), so +20% would be about a 27% two-year CAGR, which is re-acceleration. On my derivation (Q4s are derived), TTM growth is about 25% against 22.8% in FY26. That isn't enough at this multiple, but it isn't decelerating either.

Earnings quality has two separate questions. - Is the cash real? You're right that "OCF is 2x NI" doesn't answer the NI-vs-EBIT gap. But I don't need Q1's timing-inflated $902M for that. Across FY24-FY26, cumulative OCF is $3.01B against net income of $2.00B, and FCF is $2.16B (about 1.08x). The caveat is that OCF adds back SBC, whose cash cost likely sits in financing outflows (-$548M in FY26). - Why does NI exceed EBIT? On your 5% × $3B, interest is about $150M a year, close to the $167M TTM gap, which implies roughly zero net tax. The quarterly swing (-$125M in Q4, +$179M in Q1) looks like tax timing. That is unverified. I'll treat $0.97 EPS as unreliable and anchor on revenue, EBIT and FCF.

The "held by $0.26" point. My trigger was a close below ~$217, and 10-20 closed at $221.06. The $217.26 was an intraday print. Still, the closing low of $221.06 is below $224.89, so it's a lower low on closes, as I conceded. I never argued the trend is up. I agreed the weekly SuperTrend is down.

Qualcomm. Two clarifications. My settlement inference came from the MT Newswires headline, not @jd4308, and I flagged the retail "5-year pause" claim as unverified. You're right, though, that a settlement isn't automatically relief, since it could reprice. Kill criterion #3 is open, not triggered, and the dataset can't size it. That argues for position size, not for a conclusion in either direction.

3. Your two questions¶

"If Q2 opex grows 28% again, does the thesis survive?" The operating-leverage leg doesn't, and I'd cut hard. My revised kill criteria are now disjunctive: 1. Q2 operating income below $163M (opex above ~$1.18B at +22% revenue). 2. Q2 revenue growth below 20%. 3. A monthly close below $198.17. 4. Qualcomm terms that cut royalty visibility.

"What price is too high?" On the file's own illustration (20% growth to $12.8B), getting back to today's $242B at a 40x exit requires about a 47% net margin. The last three years ran 18-21%, and FY23's operating margin peak was 25%. So I can't defend $227 as a five-year hold on a 20%-growth base case. The price already assumes longer or faster growth than three years of data show.

My case is therefore narrower than "cheap": - The business shows no deterioration in growth, gross margin or cash. - The multiple has halved. - There is a hard test in the next 2-3 weeks. - The position should be small enough that a stop at $198 is survivable.

My own targets also embed multiple expansion. $271.64 is about 56x TTM sales and $333 is about 69x. I'll treat $272 as a trim zone unless margins have proven out. That is the valuation test my kill list was missing.

Where we actually disagree¶

We agree on business quality, and your three "turn constructive" tests are fair. The real disagreement is whether to wait for a reclaim of ~$255 (+12.5%) before acting. Waiting costs about 12.5% if the print is good. Not waiting costs about 12.6% down to the regime line if it isn't. That is a sizing judgment, not a verdict on the business, and I'd rather hold the defined risk small than pay for confirmation. Bull Analyst: # Bull Closing: Two Bars, a Smaller Position, and Real Odds on the Print

You landed two clean hits, so I'll answer your questions first.

1. Your two questions¶

Why $163M and not $196M? I used one number for two jobs. $163M (flat YoY) is where I'd say the leverage leg is broken. It is not where I'd say leverage returned. That test, which was my original one, sits near your $196M, where opex grows with revenue. A print at $163M would be "didn't get worse," not "leverage returned," and I shouldn't have called it a pass.

On opex, you're also right about two things: - YoY growth of +27.6% for FY26 and +27.8% in Q1 is the trend, not a tail branch. - Your $1,235M row is the wrong analog, but not in my favor. The trailing average includes the +13.9% Q4→Q1 jump that's already in the base. The seasonally matched step is last year's Q1→Q2, which was +3.7%. That gives about $1,205M of opex and about $141M of operating income. It's one data point, but it's the only matched one, and it lands on your +28% row, below my own kill line. On opex alone I'm below even odds.

The print isn't an opex-only question, though. At 97.2% gross margin, each point of revenue growth is worth about $11M of operating income (1% of $1,135M × 0.972). Holding your opex path at $1,207M: - $163M needs revenue growth of about 24.2%. TTM growth is about 25% on your derivation, and FY25 and FY26 were 23.9% and 22.8%. - $196M needs about 27.2%. On a two-year basis that is near 29% against the +34.5% comp, which would be a real re-acceleration.

Clearing $163M therefore needs a modest revenue beat or opex restraint. Hitting $196M also means opex falls about 1% sequentially, which has happened once in the last four quarters (Q4 FY26, -0.7%). My judgment is about 40% for $163M and lower for $196M. That's a judgment, not a model output. Neither of us has consensus numbers, so we can't say what the market already expects.

How do I exit through the print? I can't. I blurred a regime line (a monthly close) with an execution stop, and neither survives an overnight gap. So position size has to be set against the gap, not against the stop. - I'll use your $169 (35x sales, about -25%) as the gap marker, not $198. - If the loss budget at $169 is 1% of the portfolio, the ceiling is a 4% position. This is illustrative, so scale it to your own budget. - Pre-print I'd hold a starter at roughly a third to a half of that ceiling. The Oct 20 closing-arguments claim is unverified, but if it's right a Qualcomm decision could land near the print, which is another reason to stay small.

2. Where I still push back¶

Waiting isn't as cheap as you say. Your 12.5% assumes a good print lets me buy at $255. Your own gap evidence says otherwise: - The stock rose 17.2% in one session on 9-21. - It closed at 280.56 on 8-4, 27.9% above the 8-3 intraday low of 219.39. The 8-3 close isn't in my data, so the close-to-close gap is smaller.

A gap to $280 is +24% from here. The good-branch cost of waiting is therefore 12-25%, not a fixed 12.5%, and "reclaim $255" may never be available as an entry. With the downside gap at -25% and my p around 40%, a full-size pre-print position is about zero expected value or slightly negative. That is why my answer is size, not conviction.

The remaining concessions: - Cash. The 68% conversion ex-FY24 and the 108% including it are a window choice. FCF dollars are flat versus FY24 ($979M vs $998M) while revenue is up about 50% and capex is up 6x. The 0.18% SBC-adjusted yield assumes the whole $548M of financing outflow is SBC-related, which the tools don't show. Every cut is below 1%, and I'm not claiming FCF supports the price. - EPS. A near-zero implied tax rate isn't a steady state, and $0.76 at 20% tax is a fair illustration. I anchor on sales, EBIT and FCF. - Valuation floor. There isn't one, and I never claimed one.

3. What still holds¶

Growth: The business has grown 20%+ for four years, and Q2 faces the toughest comp in the series.
Gross margin: It stayed at 97.2% through the opex ramp. The whole debate is about opex, which the November 10-Q (SBC, R&D) can test.
Convexity: Opex is sticky and gross margin is 97%, so operating income moves about $0.97 per extra revenue dollar. Q4 FY26 earned a 29.4% margin on $1,490M of revenue.
Self-funding: The company pays for $588M of TTM capex from its own cash, with $3.06B on hand and no refinancing risk.

4. Revised rules¶

Q2 FY27 outcome	Read	Action
Operating income < $163M, or revenue growth < 20%	Leverage leg broken	Exit the starter
$163-196M	Not worse, not fixed	Hold, no add
≥ $196M, revenue ≥ 20%, no Qualcomm royalty cut	Leverage returned	Add toward the ceiling, even on a gap up
Monthly close < $198.17	Regime flips	Exit regardless

The $272 trim stays in force unless margins have proven out.

Where we now disagree¶

I accept your business assessment and most of your valuation math. We've narrowed to one question: starter now or nothing until the print. I say a starter, because confirmation may arrive as a gap you can't buy.

Two questions for you: 1. If Q2 prints $180M of operating income on +26% revenue, is that a pass or a fail under your bar? 2. If confirmation arrives as a gap through $255, do you chase or skip? If you skip, your "waiting is cheap" case depends on the print disappointing. Bull Analyst: # Bull Close: Smaller Starter, Tighter Rules, One Check Left to Run

You've reduced this to the right question. I'll take what's correct in your close, then show where the break-even table claims more than its inputs support.

1. What I take¶

Qualcomm dropped out of my exits. You're right, and I've added a row below. Like every other row, it executes after a gap, not before it.
"Convexity" was the wrong word. At fixed opex, operating income is linear in revenue, about $11M per point in both directions. Your $84M downside case is correct arithmetic. Revenue growth has also run 12.1% → 34.5% → 26.3% → 20.1% → 22.4%, so a 5-point miss is inside the historical range, and Q2 has the toughest comp. Nothing structural favors me here.
Gap-chasing in this stock has been costly. $280.56 is -19% and $322.90 is -30%.
On $180M and +26% revenue we agree. It's a half-pass, so hold and don't add. We'd also both add on a fully confirming print, so post-print behavior is identical.

2. Where the break-even table overreaches¶

The algebra is right: P(full pass) × 24% = 60% × g. My objections are to what goes into it.

It maps thesis tests onto price outcomes. My <$163M line says when I exit the starter. It isn't a forecast that the stock falls 25%. We have no consensus numbers, so a "fail" may already be priced and a "pass" may get sold. The table treats a 60% chance of failing my test as a 60% chance of the bad-branch move, and nothing in the dataset supports that mapping.

The answer is driven by g, the one input neither of us measured. Solving for g gives g = 40 × P(full pass). At a 20% full-pass probability (my "lower than 40%"), break-even is a miss costing about 8%. At 40% it's 16%. Your table's -25% row needs 62.5%. I'll be plain about this: if a miss costs much more than 8%, the starter loses on my own odds. That is likely for a stock with a 7% ATR. The sign of the answer flips on an input we can't observe.

Your reason #2 cuts both ways. You argue the 32% drop tracked a sector selloff and the Qualcomm headline, not an ARM-specific cut to Q2 expectations. If so, a print that merely holds expectations has a drawdown to recover, so the good branch isn't limited to my "full pass" bucket. I can't prove that either, since no analyst revisions are in the data. But it is the same kind of assertion as "the miss is priced," and neither is testable here.

Gap behavior argues for scaling in, not just for waiting. Gaps in this stock haven't held, and you say a margin-confirming gap would. That's plausible but unproven. The premium you pay after the print buys information, not price protection. I'm changing my table so that adds go in thirds over several sessions instead of all at the open.

One check neither of us ran. The tools don't date the Q1 FY27 report. If the 8-4 close of $280.56 (+27.9% off the 8-3 intraday low) followed that print, which showed the 7.1% margin, then the market's last reaction to a falling-margin print was up. I can't confirm that from these tools, so I'm not counting it. It is the only direct evidence on how this stock reacts to margin news, and it should be checked before the November print.

3. Revised rules¶

Event	Action
Any Qualcomm ruling or settlement showing a lower royalty rate or a payment pause, before or after the print	Exit the starter at the next open
Q2 operating income < $163M, or revenue growth < 20%	Exit the starter
$163–196M	Hold, no add
≥ $196M, revenue ≥ 20%, no Qualcomm cut	Add in thirds over several sessions toward the ceiling
Monthly close < $198.17	Exit regardless
~$272	Trim unless margins have proven out

Size. I'm cutting the starter to the low end of my range, one-third of the ceiling. On the illustrative numbers (a 1% loss budget at $169 gives a 4% ceiling), that's about 1.3% of the portfolio. Scale it to your own budget.

4. What the fight is actually worth¶

At 1.3%, a -25% gap costs about 33 bps of portfolio and a +24% gap earns about 32 bps. Under your table's harshest row, the starter's expected cost is about 14 bps. Under the 8% case it's zero. The whole dispute is about ten to fifteen basis points, which is why I call it a sizing judgment and not a conviction call.

5. Where I land¶

We agree on: - The business is real: 20%+ growth (about 25% TTM on the derived quarters), a 97.2% gross margin, $3.06B of cash and self-funded capex. - The price is demanding at 47x sales and about 270x EBIT, and there is no valuation floor. - Operating leverage has moved the wrong way for three years. The November print is the test, with $196M as the real bar and $163M as the break line. - Nothing exits through a gap, so position size is the only protection.

We differ on: whether roughly 1.3% should be owned before the print or bought after it. You'd pay 12–24% extra in the good branch for certainty. I'd pay a small, bounded loss in the bad branch for the chance not to chase.

I'll drop the starter if: - The Q1 reaction check shows the stock sold off on that print. That would raise g and put me on your side of the table. - A position sized to a ≤35 bps loss at $169 isn't practical. - A Qualcomm ruling lands first and shows any royalty cut.

If the print clears $196M with revenue ≥20% and intact Qualcomm terms, I want to be buying a business whose cost base has stopped outrunning revenue, and we'd then be doing the same thing. If it doesn't, I'll have lost a rounding error and kept the capital for the next test. Bull Analyst: # Bull Final: Same Rules, One Empirical Disagreement

You've reduced this to g, P(full pass) and u. I'll take what's right in your close, say what the table can't settle, and turn the rest into a checklist.

1. What I take¶

Sequencing. Two of my three drop conditions (the Q1 reaction and position practicality) are knowable before I buy. "Buy, then check" is backwards. The starter is now conditional on those checks being run first.
I can't run them. The dataset doesn't date the Q1 report, and it has no consensus, guidance or implied-move data. As of today, the evidence I hold doesn't authorize the starter.
u = +24% was too generous. It leans on 8-4, which I can't tie to the print. 9-21 wasn't a print at all. I'll use +17% as the central case.
Central inputs put the starter at zero to slightly negative. At u = 17% and P(full) of 20-30%, break-even is a 5.7-8.5% miss cost. I said a miss likely costs more than 8% in a stock with a 7% ATR, so I won't argue that EV is positive.
"A big fall on no news" doesn't show a miss is priced. Agreed. I'll drop that claim.

2. What the table still can't settle¶

Corner or coin flip? Break-even across the plausible cells runs from about 6% to 12%, which overlaps plausible miss costs. I'd say the starter's EV is within noise of zero, with the sign set by two inputs neither of us can observe. That is what I said last round, and I think we now agree on it.
The half-pass branch is unvalued, not zero. It carries about 20% of the probability in the central case. We have no basis for its drift, so it doesn't rescue the starter. It does mean the table is a rough guide.
Path risk is the print again. FOMC and Qualcomm are two-sided. A starter holder bears the variance, and a waiter forfeits the favorable side and pays the same premium to find out. It's the same g/u structure and doesn't change the sign. I do concede that my Qualcomm exit executes after the gap, so it limits the aftermath and doesn't prevent the move.

3. The checklist¶

Check	In our data?	Favors a starter	Otherwise
Q1 FY27 report date and next-day move	No	Stock rose or was flat on the 7.1% margin print	Flat
Q2 consensus or guided operating income and opex (confirm GAAP vs non-GAAP basis)	No	Consensus at or below about $163M, so a fail is mostly priced	Flat
Options-implied earnings move	No	At or below about 8%, with a cushion because misses usually exceed the average implied move	Flat
Position fit	Portfolio-specific	A ≤35 bps loss at $169 is achievable at about 1.3%	Flat

Rule: the sizing check must pass, at least two of the three data checks must favor it, and none may be strongly against. If any input can't be obtained, the default is flat. The Q1 reaction alone isn't decisive, because as you said the 8-4 bounce also has a sector explanation.

4. Where I land¶

We agree on: - The business: 20%+ growth, 97.2% gross margin, $3.06B of cash and self-funded capex. - The price: 47x sales, about 270x EBIT and no valuation floor. - The test: Q2 operating income of $196M or more, revenue growth of 20% or more, and intact Qualcomm terms. - The response to a clean pass: buy in thirds. - The limit of any stop: nothing exits through a gap. - The stakes: about 10-15 bps of portfolio.

What remains is an empirical prior. I lean toward thinking a $163M outcome is substantially priced, because both of us extrapolated opex mechanically from the same data and the sell-side presumably does too. I can't support that from this dataset, and you lean the other way. Q2 guidance would settle most of it, since consensus clusters around it. The dataset has none.

The bull case doesn't need the starter. The case for owning ARM rests on operating leverage returning, with opex growth converging to revenue growth on a 97% gross margin. The multiple doesn't carry it, and I've said I can't defend $227 as a five-year hold on a 20%-growth base case. If the November print clears $196M with revenue growth of 20% or more and intact Qualcomm terms, I want to be buying in thirds, and so do you. If it doesn't, we both stay out. The starter was only ever a way to buy a small option on being early, and on the evidence in hand it's worth about zero.

Bear Researcher¶

Bear Analyst: # Bear Case for ARM: Great Business, Priced for Perfection, With the Key Driver Moving the Wrong Way

You asked where the thesis breaks. I'm not arguing distress. The balance sheet is excellent and the growth is real. My argument is that the price already assumes everything goes right, the one thing that could justify it (operating leverage) is reversing, and the "floor" you describe has already been undercut.

1. "The price has already reset" assumes the peak was the baseline¶

The stock fell 48% from $439, but the business didn't double in value between December and June, so the peak is a poor anchor. My approximate math (derived quarters, constant share count):

At the peak: about 95x TTM sales.
A year ago ($169.38): mid-40s.
Today: about 47x.
At the December low ($109.31): about 25x.

The "reset" put ARM back near the multiple it had a year ago, and that was before the stock fell 35% in two months. On operating income it's worse. TTM EBIT of $877M against about $240B of EV is roughly 270x. You led with 234x P/E, which is the flattering measure (see section 3).

Take the fundamentals file's own bull scenario: 20% growth for five years at a 25% net margin gives about $3.2B of earnings. Today's cap is 76x that. Give ARM a still-generous 40x in 2031 and the market cap is about $128B, 47% below today, with everything going right. You've told us valuation is "a risk to size for." I'd ask what price you'd call too high, because your kill criteria contain no valuation test.

2. Margins: your three mitigants don't hold¶

"Q1 is seasonal." Q1 is compared with Q1: 19.4% → 10.8% → 7.1%. Seasonality is already controlled for.
"Revenue fell 13.5% sequentially while the cost base didn't." The cost base didn't just hold, it rose 14% sequentially ($1,020M → $1,162M), and it's up 28% YoY against 22.4% revenue growth.
"Q4 hit 29.4%, and TTM is 17.0%." Q4 FY25 was about 33%, so the strongest quarter also slipped. TTM margin has gone 25.0% (FY23) → 20.7% → 18.3% → 17.0%. That is the trend, not a rebuttal.

The 97% gross margin cuts against you too. With gross margin flat, operating income is entirely an opex story, and you've said the data doesn't tell us what the opex funds. Capex is up 6x in two years to about 11% of revenue, which is not what "software-like" looks like.

If Q2 simply repeats Q1's pattern (revenue +22% to about $1.39B, opex +28% on $943M), operating income is about $145M, roughly 10% lower YoY at a ~10% margin versus 14.4%. That's my extrapolation, not a forecast. It shows how little it takes for the print to disappoint at 47x sales.

Your kill criterion is also conjunctive: Q2 margin near 7% and growth below 20%. Margin could stay at 7% with 21% growth and you'd still be long.

Growth isn't accelerating either. It went 34.5% → 26.3% → 20.1%, and the 22.4% rebound is against a 12.1% comp, about 17% annualized over two years.

3. Earnings quality and cash¶

Q1 net income was $270M against operating income of $91M, and TTM net income ($1.04B) exceeds TTM operating income ($877M). Even 5% interest on $3B is only about $38M a quarter, so roughly $140M of the Q1 gap is unexplained. "OCF is 2x net income" doesn't answer that, because it's a different question.
The cash flow itself is flattered. Q1 OCF of $902M was 3.3x net income and 2.7x the year-ago quarter, which the fundamentals report reads as working-capital timing. That quarter sits inside your TTM $2.09B. FY25 OCF was $397M.
FCF yield is 0.55-0.62%, or 160-180x FCF.

4. The technical floor has already been undercut¶

217-225 isn't intact. The 10-20 close of $221.06 is below the 7-29 closing low of $224.89, and the $217.26 intraday low is below the 8-3 low of $219.39. Your "first warning" level held by $0.26. A lower high ($333 vs $439) followed by a lower low is a downtrend by definition.
A rising 200-SMA confirms nothing. It rises about $0.50 a day because it's dropping December-January closes near $110 and adding closes above $220. It would keep rising even if the stock fell to $200. Price is 0.7% above it, against a 7% daily ATR, on a provisional 1.8M-share bar.
"Fading momentum" is a derivative of a derivative. MACD is -13.74 against a -6.21 signal with no crossover. RSI bottomed at 32.84 and never reached 30, and it made a lower low alongside price, so there's no divergence. No Z-score reaches ±2. The heaviest sell day was 6.8M shares versus 34.2M at the peak, so there is no washout. The tech report itself calls the OBV divergence low-confidence and notes OBV overcounts up-closes.
The risk/reward breaks your own rule. You said a stop inside one ATR is noise. Your $217 stop is 0.6 ATR away. The $198 stop is 1.8 ATR away, which is a routine move for this stock, and a monthly close can only be checked at month-end. Your first target ($271.64) sits at the top of a supply stack (10-EMA 243.58, ~255, 50-SMA 265, Bollinger mid 271). The 3.7:1 depends on a +47% move to $333, with no probabilities attached.
Hierarchy: the weekly SuperTrend is DOWN, and the tool framework ranks it above the monthly.

5. Positioning and macro: you leaned on what you said you wouldn't¶

The 9.8k calls to 1.5k puts is a single retail post. It can't tell us whether the calls were bought or sold. The $230C setup in that same feed invalidates at $217.26, your exact level, so it's a crowded level. One trader flipped from bearish to adding within a day.
The sample is 30 messages with 10 labels, no Reddit, and "Low" confidence. Retail fear is in the words, but not yet in a volume washout.
The institutional headlines are factual negatives (verdict, breach, valuation). The positives are largely Motley Fool pieces.
You cited the 10% AI-bubble-burst odds as comfort, but they rose 3.5pp this week. A 14% hike risk and a 97% chance of no cuts means no easing tailwind for a long-duration, beta-3.8 asset. FRED failed entirely, so we have no VIX or yields, and "macro improved" rests on prediction markets alone.

6. Qualcomm is unresolved forward risk¶

The 5% down day is not the risk. The risk is what comes next. We both admit we can't tell who won what. The headlines say "verdict risk grows" and "faces license breach questions." Qualcomm is a major royalty payer, and nothing in the dataset sizes that exposure, which is a poor basis for paying 47x sales.

"Reluctant to intervene" leading to a settlement is your inference. A settlement with a licensee that just won a breach ruling could come at a lower rate, so it isn't automatically relief. Your evidence that the judge protects Arm's payments is @jd4308, the author you discounted for supplying 5 of 8 bullish tags and a "900%" claim. Your own kill criterion #3 is live today.

7. Insiders¶

0.03% of market cap is a denominator trick, because the question is direction, not size. There have been zero open-market purchases since March while the stock fell 48%, and the CFO sold at $300 a month ago. I'm not calling it a signal of doom, since insiders also sold at $160-$215. I'm saying it can't be waved away.

Where the thesis breaks¶

Valuation: 47x sales and 270x EBIT leave no room for even a good outcome, and the bull scenario still loses about half.
Leverage: opex is growing 28% against 22% revenue growth, and you can't say why.
Support: the floor was undercut, and there's no oversold or capitulation signal.
Overhangs: Qualcomm is unresolved, and SoftBank's capital allocation was never addressed.

I'd turn constructive on evidence, not price. That means Q2 operating margin above last year's 14.4% with opex growing slower than revenue, Qualcomm terms that show royalty rates intact, and a reclaim of the 10-EMA and ~$255.

Two questions for you: - If Q2 opex grows 28% again, does your thesis survive? - What price is too high? Bear Analyst: # Bear Rebuttal: You've Conceded the Hold, So What's Left Is a Trade

Your concessions were candid, and I'll match them. I accept that revenue growth is real, with TTM about 25% on my derivation. I accept that the balance sheet is excellent, that your trigger was a close below ~$217 and not the intraday print, and that Q2 faces the toughest comp. I'm not contesting the business. The disagreement is about price and timing, and your concessions leave a long thesis that's narrower than your close implies.

1. You moved the goalposts on operating leverage¶

Your original thesis was that operating leverage returns once the cost base stops outrunning revenue. Your revised pass line is Q2 operating income of at least $163M. That requires opex of about $1,183M, which is +25.5% YoY against +22% revenue. The cost base would still outrun revenue by 3.5 points. A flat-income quarter means margin falls again, from 14.4% to about 11.8%. That is "leverage didn't get worse," not "leverage returned."

Q2 opex	Op. income	Margin	vs $163M
$1,235M (+6.3% QoQ, trailing-4Q average)	~$111M	8.0%	-32%
$1,207M (+28% YoY)	~$139M	10.0%	-15%
$1,183M (+1.8% QoQ, your pass line)	~$163M	11.8%	flat
$1,150M (opex grows with revenue)	~$196M	14.2%	+20%

(Same assumptions as yours: Q2 revenue about $1,385M, 97.2% gross margin.)

I also don't accept that Q1 was a one-time "level shift." Quarterly opex ran $909M → $943M → $1,027M → $1,020M → $1,162M. YoY opex growth was 27.6% for FY26 and 27.8% in Q1, so the +28% case is the established trend, not a tail branch. Your pass line needs only +1.8% sequentially, and three of the last four sequential changes beat that (+3.7%, +8.9%, +13.9%). Four data points aren't a model, but on this evidence "coin flip" is generous.

2. "No deterioration in cash" doesn't hold¶

Your 1.08x FCF-to-net-income figure is arithmetically right but leans on FY24. That year's net income was depressed by what looks like IPO-related stock comp (the report's inference, not confirmed), and capex was only $92M. Excluding it:

FY25–FY26: FCF $1.16B against net income $1.70B, a 68% conversion.
FCF margin: 30.9% (FY24) → 4.4% → 19.9% (FY26), while capex rose 6x.
TTM FCF only looks better because of Q1's $902M OCF, which you conceded was timing-inflated.
SBC: you said its cash cost likely sits in financing outflows. If so, FY26 FCF less the -$548M of financing is about $431M, a 0.18% yield. That is conditional on your assumption, since the tools don't break out financing.

On earnings, your explanation (interest of about $150M explains the gap, so the net tax rate is roughly zero) implies a near-0% tax rate, which isn't a steady state. At an illustrative 20% rate, TTM EPS is about $0.76, which is roughly 300x. You've dropped $0.97 EPS, and the 74x forward P/E rests on an unverified non-GAAP basis. What remains is 47x sales, ~270x EBIT and 160-180x FCF, all worse than the 234x you started with.

3. The valuation concession undermines the position¶

You said you can't defend $227 as a five-year hold, because $242B at a 40x exit needs a ~47% net margin against 18-21% historically. You also said risk/reward isn't an edge and macro is neutral at best. That leaves a trade on one print, and "the multiple has halved" is the peak anchor you already conceded.

There is no valuation floor in sight:

35x sales (still well above December's ~25x) is about $169, or -25%.
25x is about $121.
Your $198 regime line is still about 41x sales, roughly last year's multiple.

4. The defined risk isn't defined¶

The stop can't be enforced through the print. Your only endorsed stop is a monthly close. October's bar closes 30 Oct, probably before earnings (the date is unconfirmed, and "early November" is only prior-year timing). November's closes 30 Nov, weeks after. A gap through $198 on the print goes unchecked until then.
Gaps are normal for this stock. It went +17.2% on 9-21 (275.61 → 322.90 on 13M shares) and closed at 280.56 the day after the 219.39 low. With a 7% ATR, "12.6% risk" is a floor on the loss.
A second event may be stacked. The retail post you discounted mentions closing arguments on Oct 20. If that's accurate, a Qualcomm decision on terms may also be pending. It's unverified, but you've already agreed a settlement could reprice royalties.

5. Waiting costs less than you say¶

You framed it as symmetric: waiting costs 12.5% if the print is good, and not waiting costs 12.6% if it's bad. It isn't symmetric.

The upside is capped by your own rule. You'd trim at $272, +20%, inside the 243-272 supply stack.
The downside isn't capped at $198, for the reasons above.
At p = 50%, expected value is near zero before gaps. If the trend evidence above is right, p is below 50%, and EV is negative.
Waiting buys information. If the print is good, I pay up to ~12.5% to remove the bad branch. If it's bad, I pay nothing.

Where I land¶

I'd sharpen my own bar to match the math: opex growth at or below revenue growth (about $1,150M or less, operating income of $196-199M, margin around 14%), revenue growth at or above 20%, and Qualcomm terms that keep royalty rates intact. Meeting those is a better signal than any technical reclaim. Until then, ARM at 47x sales is a good business with an unsized legal overhang and a margin trend that has fallen for three years.

Two questions: 1. Why is $163M the pass line instead of $196M, when "cost base stops outrunning revenue" was your own original test? 2. How do you exit through the print if the only stop you endorse is a monthly close? Bear Analyst: # Bear Closing: We Agree on the Facts, and the Starter Still Loses on Your Own Odds

Your rules table is a real improvement on your opening case. You started with "falling knife is the wrong label" and ended with a 1.3-2% starter, 60% odds of exiting it, and an admission that a full-size pre-print position is about zero expected value. I'll answer your two questions, then show where the starter fails.

1. Your two questions¶

$180M of operating income on +26% revenue: pass or fail?

The numbers are revenue of about $1,430M and gross profit of about $1,390M at 97.2%. That implies opex of about $1,210M, which is +28% YoY against +26% revenue, and a 12.6% margin against last year's 14.4%.

Revenue: pass.
Leverage: fail. Opex still outruns revenue by about 2 points. "Opex grows with revenue" at +26% would be about $1,188M, or roughly $202M of operating income.
Overall: half a pass. It lands in your own "$163-196M: hold, no add" row. At that print you and I would do the same thing, which is nothing more.

Gap through $255: chase or skip?

I chase, if all three tests are met. Opex growth should be at or below revenue growth, revenue growth should be 20% or higher, and Qualcomm royalty terms should be intact. My bar was always evidence, not price. Paying 12-24% more to resolve the bad branch is the premium I accept. You accept the same premium, because your table says to add "even on a gap up." So the only difference between us is the starter, a small slice bought at $227 instead of ~$280.

You'd call the 8-4 and 9-21 gaps proof that confirmation may not be buyable. Both are underwater today: $280.56 is -19% and $322.90 is -30%. Fair objection that neither was a margin-confirming print, so a real confirmation should hold better. That's why I'd chase that gap and not those.

2. Why the starter still loses on your numbers¶

You put the pass probability at about 40% for ≥$163M and lower for ≥$196M, so the fail branch is about 60%. Take your own gap markers, +24% (to $280) in the good branch and a loss in the bad branch. The starter's size cancels out of the break-even:

P(full pass) × 24% = 60% × bad-branch gap

Bad-branch gap	P(full pass ≥$196M) needed to break even
-15%	37.5%
-20%	50%
-25% ($169, the 35x marker)	62.5%

Your total pass probability is 40%, and the full-pass bucket is "lower." Even the best row needs nearly every pass to be a full pass. The other rows need more than your entire pass probability. By your own odds, the starter has negative expected value.

The 35x marker ($169) is my illustration, not a forecast. The honest escape is that a miss is mostly priced after a 32% drop in four weeks and costs only about -8%, which brings break-even down to about 20%. That is your best argument, and neither of us can test it, because we have no consensus numbers. I'm skeptical for three reasons: - The stock is still at 47x sales. - The drawdown tracked a sector selloff and the Qualcomm headline, not any ARM-specific update to Q2 expectations. - This stock moved -5% on a verdict headline and +17% in one session on 9-21, so I wouldn't assume reactions are small.

3. Two holes in the rules table¶

Qualcomm dropped out of the exits. Your revised kill list had four items, including "Qualcomm terms that cut royalty visibility." The table keeps it only as a precondition for adding, so an adverse ruling arriving before the print triggers nothing. The Oct 20 closing arguments are unverified, but if they're accurate a ruling could land inside your holding window.
Row 1 is a stop after the gap, not protection against it. "Operating income <$163M: exit the starter" executes after the stock has already gapped. It locks in the loss and prevents none of it. You've admitted nothing can exit through the print, so the table governs the aftermath only.

The convexity you cited as a positive cuts both ways. Each point of revenue is worth about $11M of operating income, so a 5-point revenue shortfall takes your $139M case to about $84M. Revenue has been lumpy, with a 13.5% sequential drop last quarter, and the same 97% gross margin that amplifies a beat amplifies a miss.

4. Where I land¶

The business: I'm not contesting it. Growth of 20%+, a 97% gross margin, $3.06B of cash and the balance sheet are all real.
The setup: The stock is at 47x sales and about 270x EBIT. It is below the weekly SuperTrend and the 50-SMA, with no capitulation volume. Opex is growing about 28% against about 22% revenue growth. Your own odds say a miss is more likely than a pass, and there is an unsized Qualcomm overhang.
The action: I'd stay flat through the print and act on evidence. I'd buy a confirmed gap with the three tests above, and I'd skip a gap on a half-pass like the $180M case. If I'm wrong, the cost is paying up 12-24% on a good print for certainty.
The residual disagreement: It is narrow. You are paying for an option on a gap-up confirmation, and by your own odds the option costs more than it returns. I'd rather pay the premium after the information arrives than before. Bear Analyst: # Bear Final: After the Print We Do the Same Thing, and Before It the Starter Needs Two Optimistic Inputs at Once

Your close narrows the dispute to one number, the cost of a miss, and I'll treat it that way. I'll concede what's right first, then show what the starter needs to work.

1. What I concede¶

The -25% row was an illustration. The $169 marker (35x sales) came from my valuation math, not from any measured reaction to a miss. Mapping "fails your test" onto a price move is an assumption, and I made it too.
"Reason #2 cuts both ways" is fair. If the 32% drop was sector and Qualcomm headlines, an in-line print could rally. No revision data exists, so neither of us can test that.
Adding in thirds over several sessions beats adding at the open. I'd use that rule too.
The stakes are about 10-15 bps. I agree this is a sizing argument, not a verdict on the business.

2. The starter needs two corner inputs together¶

With a 60% fail branch, the break-even miss cost is g* = P(full pass) × u / 0.6, where u is the gain on a clean pass.

u (gain on a clean pass)	P(full) = 20%	30%	40%
+24% (the 8-4 bar, to $280)	8.0%	12.0%	16.0%
+17% (the 9-21 bar)	5.7%	8.5%	11.3%
+10%	3.3%	5.0%	6.7%

Your central case lives in the top-left cell: a clean-pass probability of 20% and a +24% gain, so a miss must cost under 8%. Two problems follow.

The +24% rests on the 8-4 bar, whose cause you say you can't tie to the print. The other gap in the data, 9-21 at +17.2%, wasn't a print at all. Using 17% moves break-even to about 5.7%. You've already said a miss likely costs more than 8% for a stock with a 7% ATR.
"A miss is already priced" hasn't been shown. The stock fell 26.3% from 10-02 to 10-20, and 32% from 9-22, with no ARM-specific data beyond a Qualcomm headline. A large fall on no new information doesn't show that expectations were cut. It may show only that beta of 3.8 is doing what beta does.

The table also covers only the print. The starter carries the whole path to it: - FOMC, 28-29 Oct: a 14% hike tail and 97% odds of no cuts. - The Qualcomm ruling: the headlines read bearish, retail reads them bullish, and you've agreed the dataset can't size it. Your exit for it executes at the next open, after the move. - A tape with no washout: RSI is 35.7, not oversold, and the heaviest sell day was 6.8M shares against 34.2M at the peak.

3. Your drop conditions can be checked now¶

Two of your three are known before you buy: the Q1 reaction check and whether a ≤35 bps position is practical. Running them after you own the stock puts the sequence backwards. A zero-cost wait of a day or two would settle them.

I'll make the check symmetric. If the stock rose on the 7.1% margin print, g falls and I move toward you. I can't run it either, because the dataset doesn't date the Q1 report. I also don't want to lean on it either way, since the 8-4 bounce is equally consistent with a sector bounce off a closing low.

Two inputs would turn this from rhetoric into arithmetic, and neither is in our data: - Consensus Q2 operating income and opex. Your $163M and $196M lines come from our own cost math, but the stock reacts to the gap versus consensus. If consensus sits near $163M, a "fail" is mostly priced. If it sits near $196M, your pass line is the market's bar and a half-pass is a miss in price terms. - The options-implied earnings move. It bounds how large g plausibly is.

4. Where we land¶

We agree on: - The business: 20%+ growth, a 97.2% gross margin, $3.06B of cash and self-funded capex. - The price: 47x sales and about 270x EBIT, with no valuation floor. - The test: Q2 operating income of $196M or more, revenue growth of 20% or more, and intact Qualcomm terms. - The response to a clean pass: buy it, in thirds. - The limit of any stop: nothing exits through a gap.

We differ only on the starter. By your own odds it needs a miss to cost under 8% and a pass to pay about 24%. I'd treat that as a corner case, not a base case, for a stock that moved -5% on a headline and +17% in one session.

My position: stay flat through the print and through the FOMC and Qualcomm window. If the print is a full pass, buy in thirds. If it's a half-pass like your $180M case, do nothing.

I'd move to a starter if: - The Q1 reaction check shows the stock rose on a falling-margin print. - The implied move is small enough to put g near 8% or lower. - Consensus operating income sits at or below about $163M, so your fail line is mostly priced.

If those hold, the starter becomes a reasonable small bet and I'd say so. Until then, the cost of waiting is the premium you identified, 12-24% on a good print, paid for certainty about a margin trend that has fallen for three years. Bear Analyst: # Bear Final: We've Converged on the Rules, but the Print Won't Fix the Price

You've conceded the starter, so I'll agree where we agree, then show what your closing still leaves open.

1. What I take¶

Your sequencing is right. Gate the starter on checks you can't run today, and default to flat. On action we're now identical: flat now, buy a clean pass in thirds, do nothing on a half-pass.
I can't prove $163M isn't priced. I lean one way and you lean the other. Neither lean is testable here.
The Q1-reaction check isn't decisive, because the 8-4 bounce also has a sector explanation.

2. The prior on "priced in" leans my way¶

You argue the sell-side extrapolates opex mechanically, as we both did, so $163M is largely priced. The one expectation-like number in the dataset doesn't fit that.

Forward EPS is $3.06 against $0.97 trailing. At about 1.07B shares ($242.3B / $226.71), that is roughly $3.3B of earnings against $1.04B of TTM net income and $877M of TTM EBIT.
If it's non-GAAP (probable, but unconfirmed), the street's lines aren't our GAAP lines. A "fail is priced" claim can't be mapped onto $163M at all.
If it's GAAP, it embeds a large margin recovery, and the real bar sits above your $196M, not at $163M.

Neither reading supports "the market already expects +28% opex." That is inference, since I can't confirm the basis. But a stock at 74x forward isn't one that has braced for a miss.

3. A pass repairs the trend, not the price¶

Swap Q2 FY26's $163M out of TTM EBIT, with EV about $239.7B:

Q2 FY27 op. income	TTM EBIT	EV / TTM EBIT
$139M (+28% opex case)	$853M	~281x
$163M (your break line)	$877M	~273x
$196M (your "leverage returned")	$910M	~263x

Your best row moves the multiple about 4%. After a clean pass the stock is still at roughly 260x EBIT and 47x sales. You've already said you can't defend $227 as a five-year hold on a 20%-growth base case, and you'd trim at $272. So the post-pass picture is about +20% to your trim against a -25% gap to the 35x marker.

I'd still buy a clean pass, because it fixes the one leg that has been breaking. But I'd size it as a trade on the trend, not as a core hold. "The bull case doesn't need the starter" is true, but the bull case also needs the multiple to hold, and no print tests that.

4. A half-pass isn't neutral¶

Your $180M on +26% revenue case is operating income +10% YoY against revenue +26%. Margin would be 12.6% against 14.4% last year, a second straight YoY margin decline. "Hold, no add" is the right action. But that outcome is the trend continuing, so I wouldn't assign it zero drift. At 270x EBIT it leans negative.

5. Two edits to your checklist¶

Implied move. You set the threshold at "≤8% with a cushion because misses usually exceed the average implied move." That cushion points the wrong way. At central inputs, break-even miss cost is 6-8.5%. If misses typically exceed the implied move, the implied move has to sit well under break-even, so ≤5% is the right line, not 8%.
Consensus basis. "Confirm GAAP vs non-GAAP" should be a hard requirement. The forward EPS suggests the street works on a non-GAAP basis, so a GAAP consensus may simply be unobtainable. Under your own default rule, that means flat.

Add a third check with the same sequencing logic: read the actual Qualcomm ruling before owning anything. It's public, it's knowable now, and it's the one unsized overhang. Your exit rule for it fires after the gap, but reading it before you buy costs nothing.

6. Where I land¶

Agreed: - The business is real: 20%+ growth, 97.2% gross margin, $3.06B of cash and self-funded capex. - The test is Q2 operating income ≥$196M, revenue growth ≥20% and intact Qualcomm terms. - Nothing exits through a gap, so size is the only protection. - The starter is worth about zero to slightly negative on the evidence in hand.

My position: stay flat through the FOMC (28-29 Oct), the Qualcomm window and the print. Buy a clean pass in thirds, sized as a trade. Skip a half-pass.

I'd move toward a starter if: - GAAP consensus sits at or below about $163M. - The implied move is ≤5%. - The Q1 reaction was positive and the ruling reads as royalty-intact.

I'd get more bearish on: - A monthly close below $198.17. - Q2 operating income under $163M. - Any Qualcomm term that cuts the royalty rate.

ARM is a good business, and the print can tell us whether its cost base has stopped outrunning revenue. It can't tell us whether 260x EBIT is a fair price for that. That is the part of the thesis no upcoming data point resolves, and it's why I'd keep the position small even if I'm wrong about the miss.

Research Manager¶

Recommendation: Underweight

Rationale: This debate converged further than most. By the end, both analysts agreed on the facts and on what to do after the November print. The bear won the parts that decide what to do before it.

The bull's case for the business holds up, and the bear accepted it: - Revenue has grown 20%+ for four years (about 22.4% in Q1 FY27, roughly 25% TTM on derived quarters). - Gross margin is 97.2%. - The company has $3.06B of cash against about $0.49B of debt and funds its own capex. - The stock is down 48% from the June high, and the monthly SuperTrend at $198.17 is still up.

The bull then conceded almost every point that would justify owning it at $227 today: - The 'reset' only looks like one measured from the June peak. At about 47x TTM sales, ARM sits near last year's multiple, and on about $877M of TTM EBIT it trades near 270x. FCF yield is below 1%. - The bull said he can't defend $227 as a five-year hold on a 20%-growth base case. The file's own bull scenario needs roughly a 47% net margin to justify today's cap, against 18-21% historically. - Operating leverage has gone the wrong way for three years. Q1 operating margin ran 19.4%, then 10.8%, then 7.1%, and TTM margin fell from 25% to 17%. Opex has grown about 28% YoY in both FY26 and Q1 against 22% revenue growth, and nobody can say what it funds. - The technical 'floor' was undercut on a closing basis ($221.06 vs the $224.89 July closing low). The weekly SuperTrend is down, there is no capitulation volume, RSI never reached oversold, and the rising 200-SMA is just arithmetic from old closes rolling off. - Net income exceeds EBIT on what looks like a near-zero tax rate, so $0.97 EPS isn't reliable. - The Qualcomm breach ruling is unresolved and can't be sized from our data.

The decisive exchange was over the pre-print starter. The bull put about 40% odds on clearing even his $163M break line, and lower on the $196M bar that would mean leverage has actually returned. On his own inputs (+17% on a clean pass, a 7% ATR stock), a miss would have to cost under 6-8.5% for the starter to break even. He finally agreed its expected value is zero to slightly negative and that his own checks should come before buying.

The bear's last point also stands: even a clean pass only moves EV/EBIT from about 273x to about 263x. The print can fix the trend but not the price. On top of that, three binary events are stacked within weeks: FOMC on 28-29 Oct, a possible Qualcomm ruling, and earnings with an unconfirmed date. No stop can exit through a gap in this stock.

So the weight of evidence is cautious rather than balanced. The business quality is real, though, and both sides would buy a confirming print. That's why I land on Underweight rather than Sell.

Missing data that could change this: - Consensus Q2 operating income and opex, and whether it's GAAP or non-GAAP. - The options-implied earnings move. - The confirmed earnings date and how the stock reacted to the Q1 print. - The actual text of the Qualcomm ruling. - Macro data such as VIX and yields (the FRED pull failed).

Strategic Actions: 1) Before the print, reduce to at most about one-third to one-half of a standard allocation, and open no new positions. Size what's left so a gap to about $169 (35x sales, roughly -25%) stays within the risk budget. As an illustration, a 1% loss budget allows about 4% of portfolio, so hold no more than about 1.3-2%. Finish the trim before FOMC on 28-29 Oct and before any Qualcomm ruling or earnings date. If price bounces into the $243-255 supply zone first, use the strength, but don't make the trim depend on it.

2) Exit the remainder on any of these: - A monthly close below $198.17. - Any Qualcomm ruling or settlement showing a lower royalty rate or a payment pause (exit at the next open). - Q2 FY27 GAAP operating income below $163M, or revenue growth below 20% YoY. Accept that each of these executes after a gap. Size is the only real protection.

3) If Q2 operating income lands between $163M and $196M (a half-pass, e.g. $180M on +26% revenue), keep the reduced position and don't add.

4) If Q2 operating income is at least $196M, revenue growth is at least 20% and Qualcomm royalty terms are intact, rebuild in thirds over several sessions toward a standard allocation, not above it. Treat that position as a trend trade, given about 260x EBIT even after a pass. Trim around $272 unless sustained margin recovery has been shown.

5) Run these checks before any re-entry or pre-print starter. All of them are missing from our data: - The confirmed earnings date. - Q2 consensus operating income and opex on a stated GAAP basis. - The options-implied move. - How the stock reacted to the Q1 FY27 print. - The actual Qualcomm ruling text. Only consider a small starter if most of these line up: GAAP consensus at or below about $163M, an implied move at or below about 5%, a non-negative Q1 reaction, and a royalty-intact ruling. If the data can't be obtained, default to the reduced or flat stance.

6) A move to Hold or higher needs both a clean Q2 pass and evidence that opex growth is converging to revenue growth, such as an SBC or R&D breakdown in the 10-Q. Turn more bearish, toward Sell, on a monthly close below $198.17 combined with a Q2 miss or an adverse Qualcomm outcome.

III. Trading Team Plan¶

Trader¶

Action: Sell

Reasoning: The plan's Underweight maps to a Sell: trim before the binary events, don't liquidate. The business is strong (20%+ growth, 97% gross margin, net cash), but at about 270x TTM EBIT, with operating margin falling from 19.4% to 7.1% and a sub-1% FCF yield, the stock is priced for a recovery that hasn't shown up. The technicals agree: the weekly and daily SuperTrends are down, price is below the 10-EMA (243.58) and 50-SMA (265.01), and the 217-225 zone (200-SMA at 225.12, July-August lows) was undercut on a close at 221.06. There was no capitulation volume, and RSI (35.70) and the Z-scores are not oversold. FOMC on 28-29 Oct, a possible Qualcomm ruling and an unconfirmed earnings date all fall within weeks, and with ATR near 7% of price a stop can't be relied on to exit through a gap. Trimming cuts that gap risk while keeping some exposure to a confirming print. The earnings date, GAAP consensus, options-implied move and Qualcomm ruling text are all missing from the data.

Entry Price: not provided

Stop Loss: 198.17

Position Sizing: Portfolio context was not provided, so size relative to your own position. Trim to at most one-third to one-half of a standard allocation before FOMC on 28-29 Oct, and open no new positions. If you hold a larger position, sell into any bounce toward the 243.58-255 supply zone, but don't make the trim depend on it. Size the remainder so a gap to about 169 (roughly -25%) stays within the risk budget; a 1% portfolio loss budget implies about 1.3-2% of portfolio. Exit the rest on a monthly close below 198.17, a Qualcomm ruling showing a lower royalty rate or payment pause, or Q2 GAAP operating income below $163M or revenue growth below 20% YoY. Rebuild in thirds only if Q2 operating income is at least $196M, growth is at least 20% and Qualcomm terms are intact.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: I'll open, since nobody else has spoken. Calling this Sell is the bold position, not the timid one. The timid moves are holding a full position and hoping the 200-SMA does the work, or fleeing to cash entirely. This plan does neither. It cuts the left tail and keeps a seat at the table for the upside.

The business is excellent: 22% growth, 97% gross margin, $3B in cash and almost no debt. But the market cap is about $242B against roughly $877M of TTM operating income. That's around 270x EBIT and a free cash flow yield under 1%. Even if revenue compounds at 20% for five years at a 25% net margin, you get about $3.2B of earnings, and today's price is still about 76x that. The 74x forward P/E leans on a $3.06 EPS that is probably non-GAAP and unverified. You're paying for perfection and getting a chart that says perfection isn't arriving on schedule.

The conservative side will say to get out entirely. I'd push back, because this stock gaps up violently. It closed at 280.56 the day after the 219.39 low on 8-3, and it jumped from 275.61 to 322.90 in one session on 9-21, which is +17%. A stop can't protect you from gaps in either direction, and with ATR at 7% of price that cuts both ways. Keeping a third to a half of a standard allocation preserves that convexity. Going to zero before the print, the Qualcomm ruling and FOMC would be paying to be right and then missing the move if the market surprises us.

The neutral side will say to hold because the 200-SMA at 225 is holding and the indicators are stabilizing. Look at what that case rests on:

The bar: today's is provisional, on 1.8M volume.
MACD: its decline is slowing, but there is no bullish cross.
OBV: the flat-since-10-12 reading is flattered by how OBV counts a +0.15 close on 6.8M shares.
RSI: price made a lower low and RSI made a lower low, so there is no divergence.
Oversold signals: none, with RSI at 35.7, Z-scores inside ±2 and no capitulation volume.

The sell-off hasn't been flushed, and a stock that is down 48% without a washout hasn't finished. The weekly SuperTrend is down with a flip level at 357.54, and the daily is down at 271.64. A reclaim of the 10-EMA at 243.58 is a 7% move, but overhead supply is stacked from there to 272.

Bullish sentiment is thinner than it looks. The 8-to-2 label split is 10 labels, with five of the eight bullish tags from one author. The 6.5x call flow comes from a single unverified post. The crowd is dip-buying with tight invalidation at 217.26, which is the 10-20 intraday low. In my judgment, that makes a clean break below it more dangerous. That inference isn't a tool output. I'd treat that crowd as exit liquidity for the sell-into-strength part of the plan, not as a reason to hold.

Macro doesn't rescue it either. The hike odds fell 20 points to 14%, which is good, but 97% of the market says no cuts in 2026. A 234x trailing multiple doesn't get a tailwind from "no change." AI-bubble-burst odds are up to 10% in a week when chips sold off.

The honest weak point is that the trim only pays if the left tail is fatter than the right over the next few weeks, and the earnings date, options-implied move and Qualcomm ruling text are all missing. I'm not claiming to know the ruling. The headlines read ambiguous, with a 5% drop on the verdict but a judge reluctant to intervene in the licensing talks. That's exactly why you size down rather than guess.

One cleanup on the sizing: a 25% gap to about 169 at a 1% loss budget implies about a 4% position, but the stated 1.3-2% corresponds to a 50-75% drawdown. The stock fell 48% in four months, so I read the lower number as deliberate stress sizing. The plan should say that explicitly.

The aggressive part is the redeployment. Trimming now buys optionality. You rebuild in thirds if Q2 operating income is at least $196M, growth holds above 20% and the Qualcomm terms are intact. You also buy a real capitulation if one comes, with volume spiking, RSI under 30 and Z-scores past -2. None of that has happened. Selling here is the active choice, because it puts you in position to buy the next confirmed move rather than the first touch of a level that has already been undercut. Aggressive Analyst: Let me take you both in turn. I'll start by giving back some ground, because a few of my own points didn't survive.

Conservative is right that shares are linear, and neutral is right that a half position through the print takes upside and downside one for one. I used "convexity" loosely. What creates the asymmetry is sizing. Cap the remainder at about 2% of the portfolio, which is the 1% loss budget at a 50% stress. The loss is then one you've already decided you can afford, while the upside stays open. I'm also dropping "down 48% without a washout hasn't finished." Neutral is right that it's a heuristic. The report says nothing flags exhaustion, which is weaker than saying another leg is coming. The exit-liquidity idea was a garnish resting on ten labels and one unverified post. The sell-into-strength zone at 243.58 to 255 is a price-level idea and stands without the crowd.

I'll also adopt the lower-of rule, the cap or the one-third-to-half fraction, whichever is smaller. That settles the sizing arithmetic we all flagged.

Once we agree on that, the rest of the fight is smaller than it sounds. Conservative says a 50% loss needs a 100% gain. That's true of a position, not a portfolio. At 2% or less, the stress case is a 1% portfolio hit that needs about a 1% gain to recover. That argument justifies the cap, which we've already applied. It doesn't justify going from a third to a quarter.

The stops are the same. On a 2% remainder, the slide from 226.71 to the 198.17 monthly line is 12.6%, which costs about a quarter of a percent of the portfolio. A daily exit at 208.45 only protects the further 4.9% below that, roughly a tenth of a percent. Set that against the whipsaw. On 10-20 the stock closed at 221.06 under the 200-SMA, printed 217.26 intraday, and was back above the average the next day. So I'm with neutral that 217 is inside the noise at 0.6 ATR. I'd go further on 208.45. It's a Bollinger band that moves with the 20-day window, so if you want a daily backstop, use a fixed price. The monthly stop is deliberately immune to a flush, which lets you sit through a washout. Neutral says a capitulation bar would collide with a stop near 198 to 208. I'd take that as a reason not to stack a daily stop on top. I'll also concede the rebuild point: buy the reclaim after the flush, not the flush itself.

On earnings, conservative is right that nothing but size protects you through the print, and that's what the cap is for. But I'd push back on calling the $163M exit line "merely flat." If revenue grows 22% to about $1,385M, $163M is an 11.8% margin. The exit fires if operating income falls year over year while revenue grows over 20%, which is a thesis break. Neutral's bracketing makes it concrete. Flat margin gives about $199M, above the $196M rebuild line, and a repeat of Q1's 3.7-point slip gives about $148M, below the exit. So there are three states: rebuild above $196M, hold between, exit below $163M.

The fundamentals list is all true: opex growth near 28% against revenue growth near 22%, capex up about six-fold, net income $179M above operating income, and a 0.55% FCF yield. But it's already the reason for the trim. It argues for being down to a third to a half, not for a quarter. On insiders, the sales are one-way, but Collins, Haas and Grisenthwaite account for about $31M of the roughly $72M, sold between about $160 and $215, below today's price. That's weak evidence of a top.

On Qualcomm, the one quantified market reaction is the roughly 5% drop, shared with AMD in a chip selloff. That's less than one day's ATR at 7%. I don't have the ruling text, so it's a data point, not proof. But it suggests the market isn't pricing a catastrophe.

On the gaps, conservative says holders got no durable gain. But the 9-22 close of 333.20 was 52% above the 8-3 low of 219.39, seven weeks later, and we're back in that zone now. One correction to neutral: the 28% is the low to the next close across two days. The clean one-session number is the +17% on 9-21. That's enough, because the plan rebuilds in thirds only after confirmation. If the print is good and the stock gaps 15 to 20% higher, the first third comes back at the gapped price. Selling below the cap to avoid a risk that's already budgeted means paying a likely cost for protection you've already bought.

On timing, I prefer neutral's version. Sell what's needed to reach the cap now, then work the rest into 243.58 to 255, with the earnings date as the deadline. Dumping everything before FOMC into a stock sitting on its 200-SMA, with a hold priced at 86%, makes less sense. Hike odds fell from about a third to 14% in a week. No cuts in 2026 is still a headwind, but the direction of the week was easing. The earnings date is unconfirmed, probably early November from prior-year timing, so whoever acts should check the calendar.

Where I land: lower of the cap or a third to a half, the monthly 198.17 stop, no daily stop at 217, a fixed-price backstop only if you insist on one, and rebuild on a reclaim in thirds. The quarter-versus-third dispute is worth a few tenths of a percent of the portfolio in either direction. When the downside is budgeted and the upside arrives by gap, I'd rather own the budgeted slice than explain why I wasn't there. Aggressive Analyst: Let me start with what you've talked me out of, because the list is long. Conservative, you're right that the monthly stop is a regime flag, not protection. It first checks on the 30^th, since the 31^st is a Saturday. That's the day after the FOMC decision, it fills wherever the stock closes, and it can't see the print at all. So I'll take Neutral's version: fixed-price daily closes, cut half of what's left under 208, exit under 198, and keep 198.17 as the monthly flag. Those levels are about 8% and 13% below price, roughly 1.2 and 1.8 ATR, so they sit outside the 10-20 noise. On a 2% slice the whole slide to 198 is about a quarter of a point of portfolio, so we're arguing over tenths. The daily version at least fires inside the window where the events are.

I'll also concede the earnings exit isn't remote. Conservative's 139 million is last year's sequential opex step repeated. Opex went from 909 to 943 between Q1 and Q2 last year, about 3.7%. The same step on 1,162 gives about 1,205, and with a 97.2% gross margin on 22% growth that's roughly 140 million, under the 163 line. That's the trend-continues case. So I now read hold-or-exit as more likely than rebuild, and I'm not counting on the print to put me back in. I'm also dropping half as a target. A third is the working number.

I still contest three things.

First, the 75% stress. Conservative, you want a 1.3% cap if we stress at 75%. A 75% drawdown from 226.71 is about $57. The 52-week low is $100.02 and the lowest close in the table is 109.31. A 50% drawdown is about $113, which means the stock gives back the entire spring advance and sits at the December low. The 2% cap already insures against a full round trip. At 1.3% you're insuring against a price nobody in this data has seen.

Second, you've both said to shade from a third to a quarter if the print is inside two weeks. But the cap is sized to a 50% loss, and the biggest one-session move anyone has cited is the 17% gap on 9-21. Even an ugly earnings gap is a fraction of what the cap was built for, so shading on the calendar alone counts the same risk twice. I'll shade if the date is confirmed close and the implied move is large, as Neutral framed it, because that's a fact about the size of the risk. Neither of us has that number, so the caller needs to check it. And at a 4% standard allocation, a third versus a quarter is about a sixth of a point of portfolio at a 50% stress.

Third, the tranche between the cap and the fraction. I agree the cap should be reached before the 28^th. A 14% hike tail is what it's for, and even if a hike took 15% off the stock, which is my number and not a tool output, that's 0.3 points on a 2% slice at 14% odds. But the extra tranche is worth a fraction of a point, and 243.58 is only about 7% away, roughly one day's ATR. So work it with limit orders into 243 to 255 and finish by the 30^th, or the session before a confirmed print. I'm not paying market-order prices for the last few tenths when the deadline is seven sessions out. Conservative, your closing line says being wrong costs a few tenths either way. I agree, which is why I won't pay a certain cost to insure a tail the cap already covers.

The aggression belongs after the print. A third of a standard allocation is a seat, not a position, and the sell side is settled to within tenths. The buy side decides whether we participate in the next leg. Neutral's gate is right: at least 196 million, growth at or above 20%, Qualcomm terms intact, then a close over the 10-EMA at 243.58 for the first third. I'd fix the other two thirds now, from the report's levels, so nobody decides them in the moment. The second goes on a close above the 50-SMA at 265.01, and the third on the daily SuperTrend flip at 271.64. Overhead supply stacked from 243 to 272 is a reason to sell into it before the print and buy through it after a clean one. That's my sequencing, not a tool output. I'd accept paying up. If a clean print gaps the stock 15 to 20%, that's roughly 260 to 272, and I'd rather own at 265 with the print and terms confirmed than at 227 with neither.

So where I land is that the Sell stands, and it's the active call, because it moves two-thirds of the risk off before three dated or undated binary events. Hold a third of standard allocation, never more than about 2% of the portfolio. Reach the cap before the 28^th and work the rest by the 30^th. Use staged daily-close stops at 208 and 198. Go to a quarter only if the date is close and the implied move is big. Rebuild in thirds at 243.58, 265.01 and 271.64 after the gates clear, and don't buy the capitulation bar. Before anyone trades it, they need the earnings date, the implied move, the ruling text and their real standard allocation, and none of those are in our data. Aggressive Analyst: I'll start with what I'm giving up, because most of what's left is you two being right.

Conservative, the 30^th is the day after the decision, and Neutral's point that the decision lands on the 29^th settles it. A finish line after the event doesn't protect against the event. So work limit orders into 243 to 255, and whatever hasn't filled goes at the close on the 27^th. That's four sessions after today, enough for a stock that moves 7% a day to touch a level about 7% away. You also caught a real inconsistency. I said I'd pay up 15 to 20% to rebuy after the print but wouldn't pay a few percent to sell before it. Both are the price of information, and at these sizes the difference is hundredths of a point, so I shouldn't have dug in. Neutral's framing is the right one. The only piece in dispute is the tranche between the cap and the fraction, and a 15% shock on that is about a tenth of a point.

On quarter versus third, I said shading for the calendar double counts the risk. That's only true when the cap is the binding number. For anyone with a standard allocation under about 6%, the fraction binds and nothing else sizes the event. So a quarter is the default, and a third only if someone confirms the print lands after roughly the 10^th. That's a calendar lookup, so nobody should be arguing about a default for something they can check before placing the order.

I also agree on the stops, the gate and the ladder levels. Write the stop as one rule: half of what's left goes on a daily close below 208 and the rest below 198, with 198.17 explaining why that number was chosen. Conservative's point that a close-based stop fills at the next open is the reason sizing does the work, since no stop sees an after-the-close print. The gate is GAAP operating income, not the EPS headline. With net income $179M above operating income last quarter, an EPS beat can coexist with operating income falling, and that print shouldn't buy anything. And 265.01 and 271.64 are only 2.5% apart, so in my own gap scenario all my rungs fire at once. Write conditions, not numbers, and give each tranche a stop under the post-print low.

Two things I'd still push on, both judgment calls.

First, speed. Neutral, you told Conservative that confirmation can arrive 20 to 30% above where you sold. That cuts against your ladder too. If the daily SuperTrend has to flip and hold for a few sessions, and the last third waits on Nvidia on the 18^th, then in the scenario where the print is good you own a third of the intended position for two weeks while this stock does what it does. I take the fade risk seriously. The 9-21 gap to 322.90 gave back 32% in four weeks. But that argues for a stop on each tranche, not for waiting on another company's earnings. I'd release the second tranche when the daily SuperTrend flips up on a close, and the third on the first higher low after that. Nvidia then becomes a risk to the stops, not a gate on ARM's own tape.

Second, the cap should expire. The 2% ceiling exists because we can't size a gap with a stop. Once the print and the ruling terms are known, the biggest dated gap risks are behind us, and a stop under the post-print low is a real, near stop with a known distance. At a 10% stop distance, a 1% loss budget supports a 10% position, so the rebuild can go back to the full standard allocation. If we trim with a risk budget and rebuild under a permanent 2% ceiling, we've turned an underweight into a standing one. That's my sizing logic, not a tool output.

One conditional thought. Conservative was right that convexity comes from options, not shares. If someone pulls the implied move and finds it modest next to a 7% daily range, a small defined-risk call in place of some of the retained shares is the one way to get what I claimed in my opening and had to take back. I haven't seen implied volatility and I'd guess it's rich, so this isn't a recommendation, just what would have to be true.

Where I land is that the Sell stands as an underweight, not an exit. Trim to the lowest of a quarter of a standard allocation (a third if the print is confirmed past about the 10^th) and 2% of the portfolio. Get to the cap now, work the rest with limits into 243 to 255, and be done at the close on the 27^th. Use the two daily-close stops, and rebuild only if GAAP operating income is at least $196M, growth is at least 20% and the Qualcomm terms are intact.

The honest weak spot is Neutral's math, which says hold-or-exit is likelier than rebuild. If so, the trim's payoff is mostly a smaller loss, not a gain, and I won't dress that up. What makes this the aggressive call is that the risk we're willing to take is concentrated where we'll have information. We carry a small, budgeted seat through the events we can't read, then move fast, with real size and a stop, when the gate clears.

Before anyone trades it, they still need the earnings date, the implied move, the ruling text and their own standard allocation. None of those are in our data, and the first one decides whether the answer is a quarter or a third. Aggressive Analyst: Most of this is settled, so I'll say where I'm giving ground and then spend my time on the one place I think the plan still has a hole.

Conservative, you caught me. Sizing off a 10% stop distance is the mistake I called out in the trader's plan in my opening, run backwards. A stop that fills at the next open doesn't size a gap, so the post-print ceiling has to come from the gap too. Neutral's version works for me. Start near 4%, which is the trader's 25% gap at a 1% budget. Move toward 6%, the 17% gap on 9-21, only after the position has survived a catalyst without a stop firing. Anyone whose standard allocation is 4% or less never touches that ceiling, so I'm done arguing it.

I'll take Neutral's rebuild timing too: the second tranche after the daily SuperTrend has flipped and held about five closes, and the third on a higher low above the flip line, at least ten sessions after the first. Conservative, you said you don't have the SuperTrend history, so the claim that it read "confirmed" near the 333 top is an inference. I don't need to win that point. Five closes is cheap, and the September fade is the case for a stop on every tranche, which we all have now. I also accept the exit on the first trade through 198 rather than the close, since a ruling can land mid-session and the remainder is half of a small slice by then. The margin floor is fine as well. At 22% growth the $196M line is already a 14.2% margin, so the floor only bites when revenue growth is hiding cost growth, and that's when you want it.

On timing we're not apart. Get to 2% of the portfolio today, because the Qualcomm ruling is undated, specific to ARM and could land tomorrow. I don't much care whether Meta is the reason. Work any remaining distance down to the fraction with limits into 243 to 255, and sell whatever hasn't filled at the close on the 27^th.

Now the hole. Every rule on the far side of the print is keyed to GAAP operating income: exit below $163M, rebuild above $196M, margin near 14%. Neutral's arithmetic says the trend-continues case lands around $140M, and hold or exit is likelier than rebuild. So the plan's most probable path is to sell the seat and stay out. That's acceptable as risk control, but it assumes the stock trades on the number the gate uses.

Look at the one data point we have. Q1 operating income fell 20% to $91M, and the stock closed at 280.56, 28% above its 8-3 low, the next day. I don't have the Q1 report date. My recollection, which isn't in our data, is that ARM reports the June quarter around the turn of July into August. It's possible, though unverified, that the sharpest rebound in our table came right around a print where the gate's number got worse. If so, the market was paying for something the gate ignores. The caller can check that in five minutes and should before trading.

My ask is narrow. If the print fails the gate but the stock reclaims the 10-EMA and holds five closes, allow a starter tranche, well under a third, with a stop under the post-print low. Conservative, I know your answer: an EPS headline can ride in while operating income falls, and September gave back 32%. That's why it's a starter with a stop under the ceiling, not a real tranche. The alternative is a plan whose likeliest outcome is out and staying out while the tape does something else. That turns an underweight into a standing one by another route. I'd pay a small, known, stopped cost to stay connected before assuming the number we picked is the one the market prices.

So the Sell stands, as an underweight and not a liquidation. The remainder is the lowest of a quarter of standard allocation (a third if the print is confirmed past about the 10^th) and 2% of the portfolio. Cut half of what's left on a close below 208 and exit the rest on a trade below 198. Rebuild only on GAAP operating income of at least $196M, growth of at least 20%, a margin near 14% and intact Qualcomm terms, staged by time and tape with a stop on each tranche and the gap-based ceiling. Don't buy the flush bar.

The call is aggressive because the risk is concentrated where we'll have information. We carry a small budgeted seat through the events nobody can read, then move with real size and a stop when the evidence arrives. Before anyone trades it, they need the earnings date, the implied move, the ruling text, their own allocation, and what the stock did on the Q1 print.

Conservative Analyst¶

Conservative Analyst: I'll start with where the aggressive analyst is right, because it helps my case. The sizing arithmetic doesn't tie out: a 1% loss budget against a 25% gap gives about a 4% position, and the plan's 1.3-2% only works for a 50-75% drawdown. And he's right that a stop can't protect you from a gap. But both points argue for a smaller remainder, not the third to a half he wants to keep.

Calling this the bold position doesn't change what it is. It's still a large position in a stock with a beta around 3.8 and a daily range near 7%, carried through Meta and Tesla earnings, FOMC on the 28^th-29^th, a Qualcomm ruling that could land any day, ARM's own print (probably early November, but unconfirmed), and Nvidia on the 18^th. His own evidence is bearish: no washout, no oversold reading, a lower low on RSI, the weekly and daily SuperTrends down, supply stacked from 243 to 272, and a valuation that still looks like 76x even in his bull case. If he believes the sell-off hasn't finished, I don't see why half the position should stay through the next leg.

The convexity argument is where I disagree most. Shares are linear, not convex. Convexity comes from options, which have a defined cost, and I haven't seen implied volatility, so I can't say whether that's cheap. As for the gaps, look at what happened afterward. The pop to 280 on 8-4 was followed by a lower high. The 9-21 gap to 322.90 and the 333.20 close on 9-22 were followed by a roughly 32% fall in four weeks. Anyone holding through those gaps got no durable gain. High realized volatility isn't an edge.

His redeployment plan also undercuts his own sizing. He says he'll rebuild in thirds only on confirmation: a Q2 operating income of at least $196M, growth above 20%, intact Qualcomm terms, or a real capitulation. If so, he doesn't need the retained half to participate, because he gets back in after confirmation. The retained half only catches the unconfirmed gap, which is exactly the risk nobody can price here. And if capitulation does come, with RSI under 30, Z-scores past -2 and a volume spike, I'd want as much cash as possible, not a half position that has already taken the losses.

On sizing, I'd go further than he did. He reads the 25% gap as deliberate stress sizing, but it isn't much of a stress. This stock fell from 169 to 109 in about ten weeks late last year, roughly 35%, and then 48% from the June closing high in four months. Drawdowns of that size are the base case, not the tail. So I'd size to a 50% drawdown, which caps the remainder around 2% of the portfolio, and closer to 1.3% if you stress at 75%. Because we don't know the caller's standard allocation, the plan should say to take the lower of that cap and the one-third-to-half rule. If the standard allocation is 5% or more, the fractional rule overshoots the risk budget.

The exit rules concern me too. The stop is a monthly close below 198.17, which is 12.6% below the current price and only checked at month-end. The October bar closes before the likely early-November print, and the next one closes after it. So the stop effectively never fires for the earnings event, and the Qualcomm trigger requires reading a ruling after the stock has already moved. The earnings trigger isn't remote either. The exit line is Q2 operating income below $163M, which is merely flat year over year, and Q1 came in at $91M against $114M a year earlier, down about 20%. Operating expenses are growing around 28% against revenue growth of 22%, capex is up about six-fold in two years, net income exceeded operating income by $179M last quarter, the $3.06 forward EPS is unverified, the FCF yield is about 0.55%, and insiders have only sold, including the CFO at $300 on 9-21. This is an excellent business, but at this price it's a poor risk-reward if any of that slips.

I'd treat the macro and crowd points the same way. The drop in hike odds to 14% is good, but 97% still says no cuts, and with FRED down we have no yields, CPI or VIX at all. The crowd is thin and noisy: five of eight bullish tags from one author, a 6.5x call-flow claim from one post, and a trader who flipped from bearish to long in a day. The dip-buyers' invalidation at 217.26 was already touched on 10-20, and I wouldn't plan on selling to them at 255.

When the neutral analyst makes the hold case, the 200-SMA will be the centerpiece. It sits at 225.12, 0.7% from price, on a stock that moves 7% a day, so it's inside the noise. Today's bar is provisional, and the technical report itself calls the MACD slowing and flat OBV tentative and low confidence. Stabilizing isn't the same as bottoming.

My adjustments to the trader's plan:

Trim size: Treat one-third of a standard allocation as the ceiling, not the midpoint, and I'd prefer a quarter. That's my judgment, not a tool output. Do it before FOMC, and don't make it depend on a bounce.
Hard cap: Keep the remainder under about 2% of the portfolio. If the position is already small or the account can't absorb a gap, exit completely.
Triggers: Add daily-close triggers alongside the monthly one. Cut again on a close below roughly 217, and exit on a close below the 208.45 lower band, instead of waiting for 198.17.
Rebuild: Keep the plan's rule of rebuilding in thirds only after the print and clear Qualcomm terms.

If I'm wrong, the cost is re-entering after confirmation at a higher price, which the plan already accepts. If the aggressive analyst is wrong, the cost is capital lost to a gap, and a 50% loss needs a 100% gain to recover. Those costs aren't symmetric, and I'd size accordingly. Conservative Analyst: I'll start with what I'm giving up, because you were both right on a few things. A close below 217 is only 0.6 ATR from price, and the 10-20 reversal shows it's noise, so I'm dropping it. The 208.45 band is a better distance at about 1.1 ATR, but Aggressive is right that a Bollinger band moves with the 20-day window, so a daily backstop should be a fixed price near 208. A 100% gain to recover from a 50% loss is a position-level statement, and at a 2% cap it isn't a portfolio problem. The insider selling is weak evidence of a top, since a good chunk of it came below today's price. I'll keep only the narrower point that nobody inside has bought a 48% drawdown.

That leads to what the debate now rests on. The cap exists because we can't trust a stop, so sizing is the only real protection. How much slack the sizing rule leaves therefore matters more than either of you is allowing.

Aggressive, you called the monthly stop deliberately immune to a flush. A stop that ignores a flush ignores the scenario it exists for. The first check is the October close, right behind FOMC, and the next is the end of November, after the print and after Nvidia on the 18^th. When it fires, you don't get 198.17. You get wherever the stock closed that day, and this stock has gapped 17% in a session. Your point that the stop only saves a quarter of a point assumes an exit at 198, which nobody can promise. So I'd call it a regime flag, not protection.

That's why half is too much. A risk budget is a limit, not a target. At half of standard, anyone with a 4% allocation or more sits exactly at the 2% cap, with the whole budget committed through FOMC, a ruling with no date and an earnings print with no confirmed date. You say the difference is a few tenths of a percent, and I agree. But those tenths cut both ways, and the information needed to price them, the implied move, the earnings date and the ruling text, is missing. The evidence we do have leans the wrong way: weekly and daily SuperTrends down, nothing oversold. When the sizes are symmetric and the edge is unknown, I take the smaller one.

On the print, I'd challenge the three-state framing, because it treats flat margins as the middle case. Last quarter operating income fell 20%, from 114 to 91, on revenue up 22.4%. By your own definition, Aggressive, that was already a thesis break, so the exit line describes the last quarter, not a remote tail. I also ran rough numbers. Q2 last year had operating expenses of about 943M. Grow that 28%, as Q1 did, apply Q1's 97.2% gross margin to revenue up 22%, and I get about 139M of operating income, under the 163M exit line. Grow expenses only 22% and I get about 195M, which is the flat-margin case. So the question is whether expense growth snaps from 28% to 22% in one quarter, with capex up six-fold in two years and Q1 margins down three years running. That's my arithmetic, not guidance, and revenue is lumpy, but the current trend lands in the exit band. The 20% growth bar also faces a tough comparison, since Q2 last year grew 34.5%.

Neutral, your December comparison helps me. By your own rough math the multiple at 109 was about 130x, and today it's about double that. Margins were stepping up then, and the latest quarter is the lowest in the table. I agree valuation isn't a timing signal, which is why I'm not selling everything on it. It's a sizing signal.

Aggressive, the 52% from the 8-3 low to the 9-22 close is a round trip. From the 7-29 close of 224.89 to today's 226.71 is up 0.8% over twelve weeks, with a 48% rally and a 32% fall in between. Volatility isn't an edge. On Qualcomm, the 5% drop was shared with AMD on a chip-selloff day, so we can't isolate the ruling's share. It tells us the first headline was digested, not what the next one costs, and we have no ruling text, damages or appeal.

On timing, Neutral, "earnings as the deadline" is a deadline without a date, and the ruling has no date either. The only dated event is FOMC on the 28^th and 29^th. I wouldn't call it 86% priced and done. Hike odds were a third a week ago and moved 20 points in seven days, FRED is down so we can't see yields, CPI or VIX, and 97% say no cuts. With a beta near 3.8, a 14% hike chance is a real input.

Where I land: the remainder is the lowest of a third of standard allocation, with a quarter if the print is inside two weeks, and about 2% of the portfolio, or 1.3% if you stress at 75%. Reach the cap now and the fraction before FOMC, and treat a bounce to 243 as a bonus, not a condition. Add a fixed-price daily-close backstop near 208 to the monthly 198.17. By Aggressive's own arithmetic it costs about a tenth of a point either way, so the tie goes to the rule that actually fires. Rebuild in thirds only after the print, clear Qualcomm terms and a reclaim of the 10-EMA at 243.58.

If I'm wrong, I re-enter 20 to 30% higher on a few tenths of a percent of the portfolio, and I've said so. If the half-position camp is wrong, it's the same tenths, plus a stop that fires after the damage. I'd rather be wrong on the side that leaves cash to act on a confirmation. Conservative Analyst: We've converged more than the tone suggests, so I'll start with what I'm taking from you both.

Aggressive, you're right about the 75% stress. A 75% drawdown from 226.71 is about $57, and the lowest close in our table is 109.31, with a 52-week low of 100.02. A 50% stress already assumes the stock gives back the whole spring advance. I'll drop 1.3% as a headline number and keep 2% as the ceiling. The short trading history since the 2023 IPO is a reason not to go above 2%, but it isn't enough to go lower. Neutral, you're right that third versus quarter is worth tenths of a point, and that stops handle a grind while only size handles a gap. I also agree with both of you that the real aggression belongs after the print.

Now the disagreements, starting with the last tranche, Aggressive. You want limit orders into 243-255 with a deadline of the 30^th, but the 30^th is the day after the FOMC decision. A deadline that falls after the event doesn't protect you from the event. If the hike tail hits, the stock never visits 243, your limits don't fill, and you sell at market on the 30^th at the post-decision price. Your own number makes the point: a 15% hit on a 2% slice is 0.3 points of portfolio, nearly a third of the whole 1% budget in one session. That's before the ruling, the print and Nvidia on the 18^th. The budget covers the whole episode, so each event spends it in sequence. Work the last tranche with limits if you like, since a stock moving 7% a day can touch 243 in four sessions. But anything unfilled should go at the close on the 27^th.

You're also inconsistent about paying up. You'll pay 15-20% above today's price to rebuy once the print and ruling terms are known, but you won't pay a few percent to sell before they are. Both are the price of buying information. I accept that cost on both sides, and on a third-of-standard slice it's small either way.

On shading to a quarter, I don't think it double counts. That's only true when the 2% cap is the binding number. Under the lower-of rule, anyone with a standard allocation below roughly 6% is sized by the fraction, and the cap does no work, so the calendar is the only thing sizing the event. Also, early November from prior-year timing straddles the two-week mark, which falls around November 4. A rule that flips on a day of date uncertainty should default to the smaller size until someone checks the calendar.

On the stops, I'm happy with fixed 208 and 198 closes, but let's be honest about what they do. A close-based stop fills at the next open. If the print lands after a close at 215, the gap goes through 208 and 198 together. So the stops cover a grind down, and the cap is what covers the gap.

On the rebuild ladder, I like fixing the thirds in advance, but not at those prices. The 50-SMA at 265.01 has been falling since its 270.50 peak on 10-13. A daily SuperTrend line in a downtrend only ratchets lower, and the 10-EMA moves with price. So write the conditions, not the numbers, or recompute the levels on the day the gate clears. The ladder also needs its own stop. Otherwise we re-enter at 265 with none of the protections we just built.

The gate should be GAAP operating income, not the EPS headline. Net income beat operating income by about $179M last quarter. An EPS beat can arrive while operating income falls, and that print shouldn't buy the first third. Neutral's math shows the $163M exit line sits in the middle of the plausible range, from about $140M with the opex trend continuing to about $185M with it flat. So hold-or-exit is the base case, and the plan should treat a rebuild as a bonus.

Putting it together, all three of us are now at Sell with a remainder, so what matters is implementation:

Size: Trim to the lowest of a quarter of standard allocation (a third only once the print is confirmed beyond about November 4) and 2% of the portfolio.
Timing: Get there by the close on the 27^th. Use limits on a slice if you want, but anything unfilled goes at market that day.
Stops: Cut half of what's left on a daily close below 208 and exit the rest below 198, with 198.17 on the monthly as the regime flag.
Rebuild: Rebuild in thirds only after the print clears GAAP operating income of at least $196M with growth of at least 20% and Qualcomm terms intact. Each tranche needs its own stop, and the entry levels get recomputed on the day.

If I'm wrong, I pay a few tenths of a point to re-enter after confirmation, which we all accept. If the half-position view is wrong, the loss is the same few tenths, but it arrives through a gap that none of our stops would have stopped. Conservative Analyst: I'll start with what I'm conceding, because there's a lot of it. Neutral, you're right that the gap isn't an extra cost on top of the tenths. It's the loss the cap is built to absorb, and my closing line counted it twice. You're also right that "when the edge is unknown, take the smaller size" cuts both ways, so it was never the argument. The calendar is the argument. A print that may land on either side of the ten-day line is a fact, and for anyone under about 6% the fraction binds and nothing else sizes the event. I'll take the 10^th as the line for going up to a third, and I agree that a daily exit under 198 and the monthly 198.17 are one rule. Aggressive, thank you for saying the trim's payoff is mostly a smaller loss. That's the honest framing, and it's why I'm comfortable with the plan.

I have two real disagreements left, and both are with your last turn, Aggressive.

First, the cap shouldn't expire the way you wrote it. You said a 10% stop distance and a 1% loss budget supports a 10% position. That's the error you caught in the trader's plan in your first turn, run backwards. Then you sized on the 25% gap to 169 and got about 4%. Now you're sizing on the distance to the stop and getting 10%. We spent several rounds agreeing that a close-based stop fills at the next open and that no stop sees an after-the-close print. A stop 10% away covers a grind, not a gap. I'll grant your underlying point: a permanent 2% ceiling turns an underweight into a standing one, so the ceiling should rise once the print and the ruling terms are known. But size it on the gap. The trader's 25% gap gives about 4%, and the 17% one-session move on 9-21 gives about 6%. And the world isn't clear after the print. The world report lists an appeal, a settlement or a damages decision as follow-ups to the Qualcomm ruling, Nvidia reports on the 18^th, and another quarter is three months out. So step the ceiling up as each tranche goes in and keep it tied to the gap. If your standard allocation is 4% or less, we agree.

Second, rebuild speed. I don't want the second tranche to fire on the first daily close above the SuperTrend line. In September the stock gapped from 275.61 to 322.90 on 13 million shares, closed at 333.20 the next day, and lost about 32% in four weeks. I don't have the SuperTrend history, so this is inference, but price was far above today's 271.64 line, and any trend-following read of that tape said "confirmed" near the top. A "first higher low" on a stock with a 7% daily range can print in three sessions, so it's noise too. You're right that Nvidia is crude as a gate on ARM's own tape. So let's swap it. The second tranche goes in after the flip has held about five sessions, and the third after the position has been held through the next dated catalyst without a stop firing. That costs some early upside in the good-print case, but it's the same few tenths we've all accepted.

On options, I'd only consider your call idea as a replacement for shares, with the full premium counted as the loss, not a delta-adjusted figure. Buying volatility before a print on a stock that already moves 7% a day is likely expensive. You guessed that yourself, and I haven't seen the numbers either. And nobody should borrow the NOV20 $230C setup from a single StockTwits post.

The rebuild gate needs one more line. Neutral showed that opex is the swing factor, with Q2 operating income ranging from about $140M to $185M depending on whether spending keeps climbing. A quarter that clears $196M while management signals another step up in spending is the Q1 pattern repeating. So the gate is GAAP operating income of at least $196M, growth of at least 20%, intact Qualcomm terms, and nothing in the commentary pointing to another jump in costs. We have no guidance data, so the caller has to make that read.

On stops, one change. A close-based rule at 208 makes sense, since it's about 1.1 ATR away and the 10-20 reversal shows intraday prints near there are noise. But 198 is about 13% below price, roughly 1.8 ATR. If the stock trades through it on a ruling or a print, nobody should have to sit through the session to see the close. Exit on the first trade below 198. That's a pre-committed rule, not a judgment call.

On timing, Meta reports after the close tonight and Tesla this week, and the world report calls mega-cap AI capex commentary a read-through for ARM. So the slice down to the cap isn't one to work with limits. It's the slice to sell today. Limits into 243 to 255 are for the tranche between the cap and the fraction, and whatever is unfilled goes at the close on the 27^th.

Where I land is close to where you both are. Trim to the lowest of a quarter of standard allocation (a third if the print is confirmed past the 10^th) and 2% of the portfolio, and get to the cap today. Work the rest with limits and finish at the close on the 27^th. Cut half of what's left on a close below 208 and exit the rest on a trade below 198. Rebuild only through the gate above, in tranches sized on the gap, with the ceiling stepping up toward 4 to 6% and a stop under the post-print low on each. Before anyone trades it, they still need the earnings date, the implied move, the ruling text and their own standard allocation. If I'm wrong, we pay a few tenths to re-enter higher. If the larger-position view is wrong, the loss arrives through a gap, which is the one risk none of our stops can cover. Conservative Analyst: Most of what's left is you two being right, so I'll go through what I'm taking and then spend my time on Aggressive's last point.

Neutral, you're correct that Meta's capex commentary tonight can help ARM as easily as hurt it, so I shouldn't have leaned on it. The reason to be at the cap today is the Qualcomm ruling: it's undated, specific to ARM, and could land tomorrow. You're also right that my "held through the next dated catalyst" gate was Nvidia on the 18^th with a new label. I'll take your version: the second tranche after the daily SuperTrend has flipped and held about five closes, and the third on a higher low above the flip line, at least ten sessions after the first. The margin floor of about 14% closes the hole in the $196M line, since a big revenue beat could otherwise pass the gate while costs run away. And you caught a real inconsistency in my sizing. I can't use a 50% stress before the print and a 17% gap right after it. I'll take about 4% as the post-print ceiling, and I'd go toward 6% only after the position survives another catalyst without a stop firing.

Now Aggressive's hole. You want a starter tranche if the print fails the gate but the stock reclaims the 10-EMA and holds five closes. I have three problems with it.

The first is the evidence. It's a recollection you've flagged as unverified, and our table has neither the Q1 report date nor the 8-3 close. If the print did land around late July, as you remember, look at what the table shows. The 7-29 close was 224.89, and the stock then set a lower low at 219.39 on 8-3. That means the stock made its lows after the print, and the bounce could have been a reflex off a level rather than a verdict on the number. The data can't separate those. Even taking your reading at face value, the market paid up to 280.56 and then gave all of it back. From there it's down 19%, and it sits within 1% of the 7-29 close. A starter that chases that reaction buys the part that didn't last.

The second is mechanical. After a gap down on a bad print, the 10-EMA sits well above price and then decays toward it. By my rough arithmetic, in about two weeks most of the gap has closed, so a couple of percent of bounce "reclaims" it on an ordinary dead-cat tape. Five closes above it on a stock that moves 7% a day isn't much of a filter.

The third is that a rule with a tape override isn't a gate. If the exit fires on a thesis break, buying back on price alone says the thesis didn't matter. That's the net-income-above-operating-income problem again: the market can bid an EPS headline while operating income falls, and we'd be paying for the thing we said we wouldn't.

I'll meet you partway, though. Staying out isn't a failure state. It's cash, and the plan is honestly reporting that its likeliest path is hold or exit. But you're right that the number we picked might not be what the stock trades on. So I'd allow a starter in one case: the filing identifies a specific non-recurring item behind the miss, so that underlying margin would have cleared the floor. Size it at no more than a sixth of standard allocation, inside the ceiling, with a stop under the post-print low. That gives you a falsifiable reason to buy instead of a price reaction. And do the five-minute lookup of the Q1 print before trading, as you said. If the stock really did rally on a worse number, that's worth knowing, and it supports a closer look at the gate, not a loosening of it.

On "out and staying out," I'd say the label doesn't matter. The seat is an underweight, the rebuild conditions are written down, and nobody is committed to a standing position in either direction.

On the rebuild, the thirds should be thirds of the lower of the standard allocation and the ceiling, not of the original position. Each one needs its own stop, sized so the distance to the stop fits the loss budget. Between $163M and $196M of GAAP operating income the answer is to hold the seat and add nothing.

So where I land is the same plan the three of us have been converging on. Trim to the lowest of a quarter of standard allocation (a third if someone confirms the print is past about the 10^th) and 2% of the portfolio. Get to the cap today, work the rest with limits into 243 to 255, and sell whatever is unfilled at the close on the 27^th. Cut half of what's left on a daily close below 208 and exit the rest on a first trade below 198. Rebuild only through the gate: GAAP operating income of at least $196M, growth of at least 20%, a margin near 14% or better, and intact Qualcomm terms. Stage it by time and tape under a ceiling of about 4%, with the narrow starter exception above.

If I'm wrong, we pay a few tenths of a point to re-enter higher, which everyone here has accepted. Before anyone trades this they still need the earnings date, the implied move, the ruling text, their real standard allocation, and what the stock did around the Q1 print.

Neutral Analyst¶

Neutral Analyst: I'll start with what you two agree on, because it's more than the tone suggests. Both of you want to trim, both want to rebuild only on confirmation, both accept that a stop can't save anyone from a gap, and both say the plan's sizing arithmetic doesn't tie out. The real fights are over the size of the remainder and the exit triggers, and each of you is half right on both.

Aggressive first. The convexity argument doesn't work. Shares are linear, so a half position through the print takes the upside and downside one for one. You also say you'd rebuild after a $196M quarter and clear Qualcomm terms. If so, the retained half only catches the move that happens before anyone has information, which is an unhedged bet, not optionality.

I'd also push on "down 48% without a washout hasn't finished." That's a heuristic, not a finding. The technical report says nothing flags exhaustion, so more downside wouldn't be unusual, which is weaker than saying more downside is likely. The stock closed at 224.89 on 7-29, about 49% below the June high, then hit 219.39 on 8-3 and closed about 28% above that low the next day. The same zone has already produced both the "not finished" reading and a violent bounce.

I'd drop the exit-liquidity idea too. It rests on ten labels, five of eight bullish tags from one author, one unverified options post and no Reddit data, and you admitted yourself that the 217.26 inference isn't a tool output. That's too thin to build a sell-into-strength plan on.

Conservative, you're right about convexity, but I think you lean too hard on the drawdown arithmetic and the tight triggers. A daily close below roughly 217 is 9.7 points from price, about 0.6 ATR. The technical report says stops inside about one ATR sit within normal daily noise, and we just saw why. On 10-20 the stock closed at 221.06, below the 200-SMA, and the next day it was back above. That rule would sell the second tranche at the zone that held in August. The 208.45 band is about 1.1 ATR away, which at least clears the noise, so I'd use that.

"A 50% loss needs a 100% gain" is true, but your own history cuts the other way. You cite 169 to 109 as the base case for drawdowns, and 109 to 439 was a 302% gain. Saying the cost of being wrong is "re-entering at a higher price" also undersells it. This stock gaps 17 to 28% in a session, so confirmation could arrive 20 to 30% above where you sold.

On valuation, you both lean on 270x EBIT and a 0.55% FCF yield. That's a good reason to size small, but it isn't a timing signal. At the December low near 109, the market cap was roughly half of today's, which was on the order of 130x FY26 operating income by my rough math, and the stock still quadrupled. Valuation tells you how little room for error there is. It doesn't tell you when the error arrives. For that you need the print, the ruling and the levels.

The plan's thresholds do real work here. Q2 FY26 operating income was $163M on $1,135M of revenue, a 14.4% margin. If revenue grows 22% to about $1,385M, a flat margin gives roughly $199M, which clears the $196M rebuild line. If Q1's 3.7-point year-over-year margin slip repeats, you get about $148M, which trips the $163M exit. So those two lines bracket whether Q1 was a blip or a trend. Conservative is right that the exit isn't remote, but that argues for a remainder sized to survive it, not for zero.

So here's the middle path:

Size: Take the lower of one-third of a standard allocation and a risk cap of about 2% of the portfolio, assuming a 1% loss budget and a 50% stress. That makes third versus quarter versus half mostly moot. For small allocations the fractions are rounding, and for large ones the cap binds. I'd hold something because the monthly regime is still up and a rising 200-SMA sits just under price.
Adjusting the size: Lean toward a quarter if the earnings date lands inside two weeks and the implied move is large. Neither is in the data, so the caller should check both.
Timing: Reach the cap before the print, not necessarily all before FOMC. A hold is 86% priced, so the idiosyncratic gap risks are the Qualcomm ruling and earnings. Sell what's needed to reach the cap now, and work the rest into 243.58 to 255 with the earnings date as the deadline.
Stops: Keep the monthly 198.17 as the last line, add a daily close below 208.45 as the second cut, and skip 217. The monthly stop can't protect against earnings, so only size handles that.
Rebuild: Rebuild in thirds on confirmation, but don't buy the capitulation bar itself. A volume spike with RSI under 30 and Z-scores past -2 probably lands near the 198 to 208 stop zone, so the stop and the buy would collide. Wait for a reclaim of the 200-SMA with RSI turning up, or of the 10-EMA at 243.58.

That keeps what both of you got right: the gap risk is cut, the stop works for grinding declines, and you're still positioned for the move that matters. Neutral Analyst: You've both moved toward the middle, so let me say what's still in dispute, because it's narrower than the tone suggests. We all accept the lower-of sizing rule, no stop at 217, a fixed-price backstop near 208 at most, and rebuilding only on confirmation. What's left is third versus quarter versus half, how fast to get there, how real the earnings exit is, and whether the monthly stop does anything. First, a correction of my own: Aggressive is right that the 28% was the 8-3 intraday low to the next day's close. The clean one-session number is the 17% gap on 9-21.

On size, put numbers on it. With a 2% cap, a third and a half only differ when the standard allocation is under about 6%. The widest gap, at a 4% standard, is about two-thirds of a point of portfolio, or a third of a point at a 50% drawdown. Aggressive, if it's tenths, then "I'd rather own the slice than explain why I wasn't there" isn't a reason to pick half over a third. Conservative, "when the edge is unknown I take the smaller one" isn't a reason either, because it applies equally to the upside. So I'd settle it with a fact, not a mood. Make a third the ceiling, shade to a quarter if the print is inside two weeks, and never go above about 2% of the portfolio. Prior-year timing points to early November but is unconfirmed, so most people will probably land at a quarter to a third. The caller should check the date.

The earnings exit is where I disagree with both of you. Conservative, your 139M is a real scenario, but it's one scenario. It assumes opex rises about 4% from Q1's 1,162M, which is what it did from Q1 to Q2 last year (909 to 943). If opex holds flat, the same 22% revenue growth and 97.2% gross margin give about 184M, which sits between the exit and rebuild lines. So opex alone moves the print from roughly 140 to 185, and the 163 exit line is in the middle of that range. Revenue matters as much, since at a 97% gross margin each point of growth is worth about 11M of operating income.

Aggressive, that means the exit isn't a remote tail, and the rebuild line is further away than you made it sound. 196M at 22% growth needs opex of about 1,150M, slightly below Q1, or a revenue beat. My read is that hold or exit is more likely than rebuild, though revenue is lumpy and I wouldn't put a number on it. That argues for being at the cap before the print, not counting on the print to put you back in. It also weakens the "good print gaps up 15 to 20% and I chase" scenario, because the good print isn't the base case.

Qualcomm is a similar problem. Aggressive reads the 5% drop as the market not pricing a catastrophe, and Conservative reads it as a first headline that's been digested. We don't have the date of that drop or the ruling text, and the stock went from about 255 to 221 over the week these headlines ran. Neither reading is supported, so the plan should key on the actual terms. I'd also drop insiders from the debate. Some sales were below today's price and some well above, and none of it is timing information. The round trip works the same way. Plus 52% in seven weeks and plus 0.8% in twelve weeks are the same stock, which says the path can't be forecast. That's an argument for a cap, not for either side.

On timing, I'd reach the 2% cap before FOMC, since a 14% hike chance is exactly the tail the cap exists for. The extra tranche between the cap and the fraction is a fraction of a point of portfolio, so it shouldn't be a fight. Conservative is right that "earnings as the deadline" is a deadline without a date, so tie it to something known. Sell the rest into strength toward 243.58-255 if it comes, but finish by the last session of October, when the first monthly bar closes. If the confirmed print date is earlier, finish the session before it.

On stops, Conservative is right that a month-end check doesn't protect you through FOMC or the print. Aggressive is right that the stop's immunity to a flush only helps if you're sized to sit through one, which is what the cap does. So I'd use fixed daily closes. Cut half of what's left on a close below about 208, and exit the rest on a close below 198 instead of waiting for month-end. Those are about 1.1 and 1.8 ATR away, so a 10-20 style reversal wouldn't trigger them. It's worth about a tenth of a point either way, but it's the version that actually fires.

One fix applies to my earlier plan and to Aggressive's. We've all listed selling into 243-255 and rebuilding on a reclaim of 243, and those only work in sequence. Before the print you're a seller into that zone. After the print and the ruling terms, the gate is the plan's: at least $196M, growth of at least 20% and Qualcomm terms intact, then a close above the 10-EMA to buy the first third. Don't buy a capitulation bar. Wait for the reclaim.

So the adjusted plan is to trim to the lowest of a third of standard allocation (a quarter if the print is inside two weeks) and about 2% of the portfolio. Reach the cap before the 28^th, finish by the October close, use the staged daily stops at 208 and 198, and rebuild in thirds after the print. That keeps a budgeted seat for the gap up and limits the gap down to a slice you chose. Before anyone trades it, they still need the earnings date, the implied move, the ruling text and their actual allocation, and none of those are in the data. Neutral Analyst: We're down to details, so I'll go point by point on who's right.

Conservative, you win the timing point. The decision lands on the 29^th, so a deadline of the 30^th falls after the event. I'm moving my finish line from the October close to the close on the 27^th. Work limit orders into 243 to 255 until then, and sell whatever hasn't filled at that close. Aggressive, this costs you little. 243 is one ATR away, and four sessions is plenty for a stock that moves 7% a day to touch it. Conservative's 0.3-point figure is also the loss on the whole 2% slice, which every version of the plan holds through the decision. What's actually in dispute is the tranche between the cap and the fraction, at most about two-thirds of a point of portfolio. A 15% hike shock on that piece is about a tenth of a point, so I'd take the version with a deadline before the event.

On quarter versus third, I'm also moving toward Conservative, for a different reason than the one given. Aggressive, you say shading to a quarter double counts the risk because the cap already covers a 50% loss. That's only true when the cap binds, meaning a standard allocation above roughly 6%. For everyone else the fraction binds, the cap does nothing, and nothing else sizes the event. Your second condition, a large implied move, is close to automatic for a stock with a 7% daily range, though that's my inference and nobody has pulled the options. And 17% is the biggest one-session move anyone has a clean number for, not necessarily the biggest that happened, since we don't have the 8-3 close. So your two conditions collapse into one, which is when the print lands. Measured from the 27^th, an early-November print is about a week and a half away. My default is a quarter, and a third only if someone confirms the date is later than roughly the 10^th. Conservative, that's your default, but the reason is the calendar. "When the edge is unknown, take the smaller size" applies equally to the upside, so it isn't an argument.

On the rebuild ladder, Conservative is right that the levels move, and neither of you named a bigger problem. Aggressive's second and third rungs, the 50-SMA at 265.01 and the daily SuperTrend at 271.64, are 2.5% apart. His own scenario is a clean print that gaps the stock 15 to 20% to the 260 to 272 area. In that scenario all three rungs fire on the same day and the thirds stop being thirds. If you want staging, stage by time and condition. Buy the first third when the gates clear and the stock closes above its then-current 10-EMA. Buy the second after the daily SuperTrend has flipped up and held for a few sessions. Buy the third after the next dated catalyst, Nvidia on the 18^th, comes through clean. Give each tranche its own stop under the post-print low.

I agree with Conservative that the gate is GAAP operating income, not the EPS headline. But the tough-comp point matters less than it sounds. A 20% growth bar means revenue of about $1,362M, a 5.7% step up from Q1's $1,289M, while last year's Q1 to Q2 step was 7.8%. That's one year of seasonality, so I wouldn't lean on it, but it suggests operating expenses are the swing factor, not revenue. The thresholds are also sensibly built. $163M is flat year over year, and $196M is up 20%, so operating income keeps pace with revenue. I still think hold-or-exit is more likely than rebuild, and nobody should count on the print to put them back in.

Both of you have a closing line I'd push back on. Conservative says the cost of being wrong is the same few tenths plus a gap no stop would have caught. The gap isn't extra. It's the loss the cap exists to absorb, and it's already inside the tenths. Aggressive says you'd rather own the budgeted slice. But a third of a standard allocation is about 1.3% of the portfolio at a 4% standard, so even a 30% gap up adds about 0.4 points. The upside seat is real, but it's small, and so is the downside. The question is no longer whether to hold a small remainder. It's whether the plan says exactly what to do on the 27^th, at 208, and after the print.

One stop cleanup. A daily close below 198 and the monthly line at 198.17 are effectively the same level. The daily exit is the monthly flag brought forward, so write it as one rule.

Here is where I land. The Sell is an underweight, not an exit, and anyone who reads it as "liquidate" isn't following the plan. Trim to the lowest of a quarter of a standard allocation (a third only if the print is confirmed past about the 10^th) and 2% of the portfolio. Reach the cap first, then work toward the fraction with limits into 243 to 255, and be done by the close on the 27^th. Cut half of what's left on a daily close below 208 and exit the rest below 198. Rebuild only if GAAP operating income is at least $196M, growth is at least 20% and the Qualcomm terms are intact. Stage the rebuild by condition and time, with a stop on each tranche, and don't buy the capitulation bar.

Before anyone trades this, they need four things the data doesn't have: the earnings date, the implied move, the ruling text and their own standard allocation. Those matter more than another round on third versus quarter. Neutral Analyst: We're down to a few real disputes, so I'll go through them, starting with two things I'm giving back.

First, the Nvidia gate. Aggressive was right that it makes ARM's tape wait on someone else's calendar. Conservative swapped it for "held through the next dated catalyst without a stop firing," but the next dated catalyst is Nvidia on the 18^th, so that's the same gate with a new label. I'd drop both and use time and tape. Buy the second tranche once the daily SuperTrend has flipped up and held about five closes, which is Conservative's number and answers the September fade. Buy the third on a higher low above the flip line, with at least ten sessions since the first tranche. The floor handles Conservative's point that a higher low can print in three days on a stock that moves 7% a day. Once flipped, the line sits below price, so it's also a stop at a known distance.

Second, the 198 exit. I'd treated the close-based and intraday versions as equivalent, but Conservative is right that a ruling can land mid-session, and by then the remainder is half of a small slice. A resting order that sells a flush like 8-3 (low 219.39, next close 280.56) costs hundredths of a point of portfolio. So I'll take the simple pre-committed trigger. It still fills at the open if the stock gaps through, so it handles a fast slide, not a gap. Selling the flush after agreeing not to buy it is fine, because we rebuy on the reclaim, not at the low.

Now the disagreements. Aggressive, the cap can't expire the way you wrote it. A 10% stop distance doesn't size a 17% one-session gap, and you made the mirror-image point about the trader's plan in your opening. Conservative, you have your own inconsistency. The same 1% budget gives 2% before the print on a 50% stress and 4-6% after it on a 17-25% gap. Before the print there's an undated ruling, an unconfirmed earnings date and a possible thesis break all at once, so the harsh stress is defensible. After the gate clears you've seen the print and the terms, so I'd use the trader's own 25% gap, about 4%, as the ceiling. Go past that only after the position survives another catalyst. Most people's standard allocation is at or below that, so this is mostly a dispute about a rare case.

On the gate, Conservative's cost worry is real, but a read of commentary is the wrong way to handle it, since we have no guidance data. The $196M line has a hole. At 22% growth it means roughly flat margins, but with a big revenue beat it can pass while margins fall. By my arithmetic, 27% growth with opex still up 28% gets you about $194M on a margin well below last year's 14.4%. So add a number: GAAP operating margin of at least about 14%, flat year over year. The two coincide at 22% growth, and the margin floor only bites when growth hides rising costs. Forward cost commentary then just sizes the first tranche smaller.

That arithmetic also sharpens what the retained seat is for. If opex repeats last year's sequential step, revenue growth has to reach about 24% just to avoid the $163M exit and about 27% to clear $196M. Growth has been 34.5%, 26.3%, 20.1% and 22.4% over the last four quarters, so a revenue surprise is plausible but not the base case. Aggressive, that supports your admission that the trim mostly pays through a smaller loss. It also supports keeping a small seat, because the payoff comes from a revenue surprise nobody can forecast. It argues against zero and against half.

On timing, I agree with selling down to the cap today, but not for Conservative's reason. Meta's capex commentary tonight can help ARM as easily as hurt it. The reason is that the Qualcomm ruling is undated, specific to ARM, and the one event that could land tomorrow. Work the slice between the cap and the fraction with limits into 243-255, and sell whatever hasn't filled at the close on the 27^th. If you're already at or below your target, do nothing and add nothing.

The plan I'd stand behind is an underweight, not an exit. The remainder is the lowest of a quarter of standard allocation (a third if the print is confirmed past about the 10^th) and about 2% of the portfolio. Cut half of what's left on a daily close below about 208 and exit the rest on a trade below 198. After the print, rebuild only if GAAP operating income is at least $196M, growth is at least 20%, margin is at least about 14%, and the Qualcomm terms are intact. Rebuild by time and tape, with a stop under the post-print low on each tranche and a ceiling near 4%. Don't buy the flush bar.

Before anyone acts on this, they need the earnings date, the implied move, the ruling text and their actual allocation. The first of those decides quarter versus third, and it's a calendar lookup. Neutral Analyst: We're down to one open fork: what the plan does if the print fails the gate. The rest I'd treat as settled, including the cap today, limits into 243-255 with the rest sold at the close on the 27^th, stops at 208 and 198, and gap-based ceilings after the print. So let me take each of you on that fork.

Conservative, your mechanical point about the 10-EMA is right, and the numbers are worse than you made them sound. A 10-day EMA moves about 18% of the remaining distance to price each session. After a gap, about 60% of the lag is gone in five sessions and about 85% in ten. So "five closes above the 10-EMA" mostly tests whether time has passed, not whether the market forgave the print. It's weak after a gap down, and after a good print gaps up, price is already above the EMA, so the first rebuild tranche is really just the gate. I'd drop the 10-EMA as a tape test.

Aggressive, I have two corrections. First, you said the plan's most probable path is to sell the seat and stay out. That overstates it. My arithmetic ran from about $140M if opex keeps stepping up to about $185M if it holds flat, with the $163M exit line in the middle. That makes exit and hold roughly even, and rebuild the less likely outcome. Hold keeps the seat. Second, the Q1 anecdote is a recollection, and Conservative's reading of the same dates is also unverified. Even if the stock did rally on a weaker number, it's one observation, and Q1 is the seasonally weakest margin quarter (7.1% against 29.4% in Q4). The market may have looked through a seasonal low, which says little about whether it ignores a year-over-year operating income miss in Q2.

Conservative, though, "a rule with a tape override isn't a gate" goes too far. Our gate is a proxy we built from sparse data, with no guidance and no R&D, SG&A or stock-comp detail. If the stock fully recovers a post-print gap, that's evidence about our proxy, not just noise. The answer is to limit what the override can do, not to ban it.

So I'd write the starter with two doors, and you can only walk through one.

The first is Conservative's. The filing identifies a specific non-recurring item behind the miss, and underlying margin would have cleared about 14%. I don't know that anything like that exists. Litigation costs or one-off stock comp are the kind of thing to look for, but the data has no opex breakdown, so the caller has to read the filing.

The second is Aggressive's, with a harder tape test. Revenue growth is still at least 20%, so the miss is on costs, not the top line, and the stock closes back above its pre-print close and holds five closes. If it gaps down 15%, that takes an 18% rally. That's a real statement from the market, unlike the EMA reclaim.

Either way, the starter is no more than a sixth of the lower of standard allocation and the ceiling, with a stop under the post-print low. It shrinks if that stop is wide. It applies only if the exit has fired and the seat is gone, since in the $163M-$196M band you already hold the seat and add nothing. The starter graduates to a full tranche only through the main gate. At a 4% standard allocation, a sixth is about two-thirds of a point of portfolio, and a 25% gap on it costs under two-tenths. The value isn't the dollars. It's that the rule is written before the print, so nobody improvises it afterward.

Conservative said the "out" label doesn't matter. It matters a little. If the plan ends in "out," it needs a date to re-run the gate, say thirty days after the print, or "out" drifts into "forgotten." That isn't a re-entry rule, just a reminder to look.

I'd leave everything else alone. Trim to the lowest of a quarter of standard allocation (a third if the print is confirmed past about the 10^th) and about 2% of the portfolio. Get to the cap today, because the Qualcomm ruling is undated and ARM-specific. Work the rest into 243-255 and finish at the close on the 27^th. Cut half of what's left on a close below about 208 and exit the rest on a first trade below 198. Rebuild through the GAAP gate: operating income of at least $196M, growth of at least 20%, margin around 14% or better and intact Qualcomm terms. Stage it by time and tape, with a stop under the post-print low on each tranche and a ceiling near 4%.

Before anyone trades this, they still need the earnings date, the implied move, the ruling text, their real standard allocation, and what the stock did around the Q1 print, plus the opex detail in that filing. That last item would settle most of what the two of you are still arguing about.

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Underweight

Executive Summary¶

The call: Underweight ARM. Treat the trader's "Sell" as a trim, not a liquidation. The Research Manager and all three risk analysts ended at the same place: cut exposure sharply before a cluster of events nobody can price, keep a small budgeted position, and let the Q2 FY27 print decide what comes next.

What to do with your own position: - Today: Sell down to no more than about 2% of portfolio. The Qualcomm ruling has no date, is specific to ARM, and could land tomorrow. - By the close on Oct 27, before the FOMC decision on Oct 29: Finish trimming to the lower of: - a quarter of your standard ARM allocation, or a third only if the earnings date is confirmed after about Nov 10; and - 2% of portfolio. - How to execute: Work the last tranche with limit orders into 243.58–255. Sell anything unfilled at the Oct 27 close. Don't make the trim depend on a bounce. - If you are already at or below target: Do nothing and add nothing. If you are flat, don't open a position.

Exit rules on the remainder: - Cut half on a daily close below 208. - Exit the rest on the first trade below 198, the monthly SuperTrend at 198.17. - Exit at the next open on any Qualcomm ruling or settlement that shows a lower royalty rate or a payment pause. - Exit if Q2 GAAP operating income is below $163M or revenue growth is below 20% YoY.

After the print: - Hold the reduced position, add nothing if operating income is $163–196M. - Rebuild only if all of these hold: GAAP operating income of at least $196M, growth of at least 20%, GAAP operating margin of about 14% or better, and intact Qualcomm terms.

Price target: 208.45 over 1–2 months, about 8% below the current price.

Investment Thesis¶

What decided it¶

The valuation leaves no room for error.
Market cap is about $242B, which is about 47x TTM sales of $5,156M.
EV/EBIT is about 273x on TTM operating income of about $877M.
FCF yield is below 1% (0.55% on vendor FCF).
The 74x forward P/E rests on $3.06 of forward EPS. That figure is probably non-GAAP and is unverified against $0.97 of GAAP EPS.
Even the fundamentals report's generous scenario (20% growth for five years at a 25% net margin) leaves today's price at about 76x.
A clean Q2 only moves EV/EBIT from about 273x to about 263x. The print can fix the trend, but it can't fix the price.
Operating leverage is moving the wrong way.
Q1 operating margin has fallen three years running: 19.4%, then 10.8%, then 7.1%.
Opex is growing about 28% against revenue growth of about 22%.
TTM operating margin has dropped from 25% to 17%.
Net income ($270M) exceeded operating income ($91M) by $179M last quarter, so EPS is not a reliable gauge.
The tape hasn't bottomed.
The weekly SuperTrend is down (357.54) and so is the daily (271.64).
Price is below the 10-EMA (243.58) and the 50-SMA (265.01).
MACD is -13.74 and below its signal line.
RSI made a lower low (32.84) with no divergence.
Z-scores sit inside ±2, and there has been no capitulation volume.
The 217–225 zone was undercut on a close (221.06 against the 224.89 July low).
The only support is the monthly regime (still up) and a rising 200-SMA at 225.12. The 200-SMA sits 0.7% from price, which is well inside a 7% daily ATR.
Events are stacked and stops can't exit through a gap.
FOMC is on Oct 28–29. A hike is still priced at 14% odds, and 97% expect no cuts.
The Qualcomm ruling is undated.
Earnings are unconfirmed but likely early November.
Nvidia reports on Nov 18.
With ATR at 15.97 (about 7%) and a +17% one-session gap on record (9-21), position size is the only real protection.
The print arithmetic favours holding or exiting over rebuilding.
Q2 FY26 opex was about $943M. With 22% revenue growth (about $1,385M) and a 97.2% gross margin, operating income ranges from about $139M (opex +28%, trend continues) to about $184–195M (opex flat to +22%).
The $163M exit line sits in the middle of that range.
Reaching $196M needs opex at or below about $1,150M, which is below Q1's $1,162M. Alternatively it needs about 27% revenue growth if opex keeps stepping up.
Exit and hold are roughly equally likely. A rebuild is the less likely outcome.

Why Underweight rather than Sell or Hold¶

Not Sell (full exit). The business is real: - Revenue growth of 20%+ for four years (22.4% in Q1 FY27). - Gross margin of 97.2%. - Cash of $3.06B against about $0.49B of debt.

The monthly regime is still up, and revenue growth has swung between 20% and 34.5% over the last four quarters. A revenue surprise is plausible but can't be forecast. A small seat sized to the risk budget captures that right tail at a known cost. The Aggressive analyst conceded that the trim pays off mainly as a smaller loss, and that framing is correct.

Not Hold. The bull side conceded it can't defend $227 as a long-term hold on a 20%-growth base case. It also conceded that a pre-print starter has expected value of zero to slightly negative.

How I weighed the debate¶

Conservative won these points: - Shares are linear, so "convexity" comes from size, not from holding stock. - The trim deadline must fall before FOMC: the 27^th, not the 30^th. - Any post-print ceiling has to be sized on gap risk, not stop distance. A 10% stop does not size a 17% gap. - The gate should be GAAP operating income, not the EPS headline. - Re-entering on a "10-EMA reclaim" after a gap is mostly a time test, and Neutral's decay arithmetic confirmed this.

Aggressive won these points: - A 75% stress (about $57) is below any price in the data, so 2% at a 50% stress is the right cap. - A stop at 217 sits inside the noise at about 0.6 ATR. - The cap should rise after the print. - Our GAAP proxy may not be what the market trades on.

Neutral supplied the synthesis: - The $140–185M bracket on Q2 operating income. - A margin floor that closes the revenue-beat hole in the $196M gate. - A rebuild staged by time and tape. - A starter exception with two entry conditions. - A quarter allocation as the default, justified by the calendar rather than by mood. For anyone with a standard allocation under about 6–8%, the fraction binds, not the cap.

Final implementation rules¶

Sizing: - The pre-print cap of 2% equals a 1% loss budget at a 50% stress. A 50% fall (about $113) would give back the whole spring advance to near the December low of 109.31. - This replaces the plan's internally inconsistent "4% → 1.3–2%".

Stops: - Use fixed levels, not the moving Bollinger band. - Cut half on a daily close below 208, which is about 1.2 ATR away. - Exit the rest on the first trade below 198, about 1.8 ATR away. - Both stops handle a grinding decline. Only size handles a gap.

Rebuilding after a full pass of the gate: - Rebuild in thirds of the lower of your standard allocation and about 4% of portfolio (1% budget against a 25% gap). - Move toward about 6% only after the position survives another catalyst without a stop firing. - First third: when the gate clears. - Second third: after the daily SuperTrend flips up and holds for about 5 closes. - Third third: on a higher low above the flip line, at least 10 sessions after the first tranche. - Put a stop under the post-print low on each tranche. - If management commentary signals another cost step-up, make the first tranche smaller. - Don't buy the flush bar.

Starter, only if the exit fired and you are out: - Size it at no more than one-sixth of the lower of your standard allocation and the ceiling, with a stop under the post-print low. - Enter through one of two conditions: - Condition A: The filing identifies a specific non-recurring item behind the miss, such that the underlying margin would have been about 14% or better. - Condition B: Growth is at least 20% and the stock closes back above its pre-print close and holds there for 5 closes. - The starter grows into a full position only through the main gate. - If you are out, re-run the gate 30 days after the print.

Options: Use them only as a replacement for shares, and count the full premium as the loss. Only consider this if the implied move turns out to be modest. Don't copy the single-post NOV20 $230C idea.

What would change the call¶

Upgrade to Hold or above requires both: - A full gate pass. - 10-Q evidence that opex growth is converging toward revenue growth, from an R&D, SG&A or SBC breakdown.

Move to Sell (full exit) if any exit trigger fires. The firmest case is a monthly close below 198.17 combined with a Q2 miss or an adverse Qualcomm outcome.

Missing data. Check these before trading: - The confirmed earnings date, which decides a quarter versus a third. - The options-implied move. - The Qualcomm ruling text. - Your own standard allocation. - The stock's reaction to the Q1 FY27 print. - Q2 GAAP consensus for operating income and opex. - Macro data such as VIX and yields, since the FRED pull failed.

Price target derivation¶

Method 1 (valuation) is not supportable here. - The reports contain no analyst consensus or fair value. - The $3.06 forward EPS has an unverified basis, probably non-GAAP against $0.97 of GAAP EPS. - No defensible multiple is supplied. - The only valuation-based level is 35x TTM sales, about $169. That is the Research Manager's gap-stress scenario, not an expected objective.

Method 2 (technical objective) is used: the Bollinger lower band at 208.45. - The technical report lists closes below about 217–219 and then the lower band at 208.45 as the deterioration path. - Given a bearish weekly and daily trend, no oversold signal, and the 217–225 zone already undercut, that is the next objective. - Distance: 226.71 − 208.45 = 18.26, which is -8.1% or about 1.14 ATR. - It sits above the 2×ATR downside (about 194.8) and the 198.17 monthly regime line, so it is not the stop.

Caveats: - The band moves as the 9-22/23 bars roll out of the window, so the 208.45 target is fixed at today's snapshot. - A clean print could instead gap the stock toward 260–272.

Current Price¶

226.71 (presumably USD) as of 2026-10-21. This is the verified snapshot. The bar is likely provisional on about 1.8M shares, and the stock-data tool shows 226.86.

Price Target¶

208.45

Confidence¶

Medium. The direction is well supported: all four inputs converged on reducing exposure, backed by consistent valuation, margin and trend evidence. The precise target is lower-confidence for four reasons: - It is a moving technical level. - A binary print, FOMC and the Qualcomm ruling fall inside the horizon. - The earnings date, implied move, consensus and ruling text are all missing. - The latest bar is provisional.

Time Horizon¶

1-2 months. This runs through FOMC on Oct 28–29, the likely early-November Q2 FY27 print, a possible Qualcomm ruling, and the 30-day post-print gate re-check.